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Translation elongation is a multi-step process orchestrated by elongation factors. 
Elongation factors G and Tu are required for each round of translation elongation, 
whereas elongation factor P is only required to assist the translation of poly(Pro) 
sequences. Upon incorporation of consecutive proline residues the ribosome is stalled; 
this stalling is alleviated by EF-P. While the catalytic mechanism of EF-P is well described, 
the determinants of EF-P binding remain unknown. Structural data and biochemical 
studies suggest the E-site codon, the peptidyl-tRNA, the ribosomal protein L1 and the 
post-translational modification of EF-P as key interaction partners during binding and EF-P 
assisted catalysis. 
In this thesis we developed a FRET based EF-P binding assay using fluorescence-labeled 
ribosome complexes and a quencher-labeled EF-P. We combined the binding assay with 
different EF-P activity assays to determine the contribution of each of the proposed 
interactions to the binding and the catalytic activity of EF-P. We found that EF-P binds to 
different ribosome complexes with similar rates. EF-P has a short residence time on 
complexes without poly(Pro) stalling sequences, which is significantly increased on 
poly(Pro)-stalled complexes. This high affinity state depends on the presence of several 
recognition elements in poly(Pro)-stalled complexes, in particular tRNAPro in the P site and 
the polypeptide chain containing several sequential proline residues. The context-
independent association rates and the determined cellular concentration of EF-P suggest 
that the sampling of ribosome complexes by EF-P is kinetically controlled by the 
availability of a vacant E site. However, only poly(Pro)-stalled ribosome complexes 
provide the interactions required for the high-affinity binding of EF-P. The dissociation 
rates from Pro-stalled and non-stalled complexes match the reported rates of 
EF-P-assisted peptide bond formation. This suggests a mechanism in which the prolonged 
residence time for stalled complexes allows EF-P to position the peptidyl-tRNA in a 
catalytically active conformation and thereby to alleviate the stalling. After peptide bond 
formation the complex returns to the low affinity state, inducing dissociation of EF-P. The 
proposed kinetic regime allows EF-P to efficiently sample ribosomes with empty E sites, to 
recognize Pro-stalled complexes with high turnover rates and to alleviate stalling in a 
single functional cycle. Thus, our work demonstrates that the recruitment of EF-P is 




A central paradigm of life is to pass the genetic information to one’s offspring. This 
process requires to store genetic information in a conserved way, while still being able to 
adjust quickly enough to a given stress. The cell achieves this by sustaining information in 
different forms using either deoxyribonucleic acids (DNA) or ribonucleic acid (RNA). DNA 
is used for long-term storage of information. DNA is transcribed into RNA. RNAs can be 
classified in non-coding or coding RNA. Non-coding RNAs either form the functional part 
of the ribosome (ribosomal RNA, rRNA), adapter molecules (transfer RNA, tRNA) or 
regulators (small or micro RNA). Coding RNAs, called messenger RNA (mRNA), provide the 
cell with a quickly accessible and easy to turn-over information source. mRNAs are 
translated into polypeptides by the ribosome, a macro-molecular machine. Proteins 
sustain metabolism, replication, motility, the cells infrastructure and architecture of the 
cell. The nexus of protein biosynthesis lies in the ribosome and its ability to perform 
translation. 
 
 Translation - a general overview 1.1
Translation is the process of protein biosynthesis carried out by the ribosome. In 
prokaryotes the ribosome is assembled by joining of the small with the large subunit, 
forming an approximately 2.5 MDa ribonucleoprotein complex. The small subunit, which 
has a sedimentation coefficient of 30 Svedberg units (S) in bacteria consists of 16S rRNA 
and 21 proteins (S1 to S21). The 30S subunit harbors the decoding center, which allows 
the decoding of the mRNA codons by tRNAs. The large subunit, with a sedimentation 
coefficient of 50S in bacteria entails 23S and 5S rRNA, and 31 proteins (L1 to L31). It 
harbors the peptidyl transferase center (PTC) that facilitates the catalysis of peptide bond 
formation. Because the catalytic center of the ribosome is formed by the 23S rRNA, the 
ribosome is a ribozyme. The ribosome is constituted of 60% rRNA and 40% protein (Ban et 
al., 2000; Nissen et al., 2000; Noller et al., 1992). 
Most tRNAs are 73 to 90 nucleotide long and adopt an L-shape. The tertiary structure 
allows tRNAs to serve as a connector between the decoding center on the 30S subunit 
and the PTC on the 50S subunit. Each tRNA features a specific anticodon for the decoding 
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of the mRNA codon and a single-stranded CCA-end which carries the corresponding 
amino acid (aa). The esterification of the aa with the 3’-hydroxyl group of the terminal 
ribose at the CCA-end of the tRNA is catalyzed by aminoacyl-tRNA synthetases (aa-RS). 
The high fidelity of this reaction is achieved by aa-RSs due to the recognition of tRNA 
identity elements in the tRNA sequence (Saks et al., 1994). 
In bacteria protein biosynthesis is initiated by the assembly of the 30S initiation complex 
by binding of the initiation factors (IFs) 1, 2 & 3, initiator tRNA (fMet-tRNAfMet) and mRNA 
to the 30S subunit (Milon and Rodnina, 2012) (Figure 2). The recruitment of the mRNA is 
independent of the IFs (Milon et al., 2012), however it is modulated by the mRNA 
secondary structure and the interactions between the Shine-Dalgarno sequence of the 
mRNA and anti-Shine-Dalgarno sequence in the 16S rRNA (Shine and Dalgarno, 1974; 
Studer and Joseph, 2006). The formation of the 30S initiation complex (IC) is completed 
when fMet-tRNAfMet recognizes the AUG start codon displayed by the mRNA (Milon et al., 
2008). Joining of the 50S subunit triggers the GTPase activity of IF2, causing GTP 
hydrolysis and resulting in the dissociation of IF1 and IF2. The dissociation of IF3 marks 
the formation of the translation competent 70S IC (Goyal et al., 2015; Grigoriadou et al., 
2007; Tomsic et al., 2000). The translation competent 70S IC provides three binding sites 
for tRNAs, the acceptor site (A site), the peptidyl-tRNA binding site (P site) and the 






Figure 1: Structure of the 70S ribosome. 
The 70S ribosome consists of two subunits, the 50S (grey/purple) and 30S (blue/turquoise) 
subunit. The ribosome has three binding sites for tRNAs, the acceptor site (A site, yellow), the 
peptidyl-tRNA binding site (P site, orange) and the exit site (E site, red). The mRNA (green) is 
bound to the 30S subunit. The PTC is marked with a star. Figure adopted from [PDB 4V89] 
(Zhou et al., 2012). 
Translation elongation entails three iterative steps: decoding, peptide bond formation 
and translocation. The overall rate of protein synthesis is 10 to 25 amino acids per second. 
This rate is primarily limited by the delivery of the cognate aa-tRNA (Bremer and Dennis, 
2008), whereas the rates of peptide bond formation and translocation must be faster. 
Aminoacyl-tRNAs are delivered   to the A site bound to EF-Tu*GTP as ternary complex, 
which is recruited by the L7/L12 stalk of the ribosome (Diaconu et al., 2005; Kothe et al., 
2004). The correct base-pairing between the delivered aa-tRNA and the A site mRNA 
codon triggers a conformational change of the 30S subunit resulting in GTP hydrolysis by 
EF-Tu and phosphate release (reviewed in: (Rodnina and Wintermeyer, 2016). The 
EF-Tu*GDP complex has a reduced affinity to aa-tRNA, allowing the accommodation of 
the aa-tRNA acceptor-end (CCA-end) in the PTC (Kothe and Rodnina, 2006). The 
accommodated aa-tRNA receives the polypeptide chain (nascent chain) of the P-site 
peptidyl-tRNA by forming a peptide bond. After peptide bond formation the ribosome-
bound tRNAs can move from the classic or the hybrid state. In the classic state the 
peptidyl-tRNA is bound to the A site (A/A) and the deacylated tRNA to the P site (P/P). In 
the hybrid state the acceptor arms of both tRNAs shift spontaneously to the adjacent 
tRNA binding sites, occupying the P/A sites and E/P sites (Adio et al., 2015; Fischer et al., 
2010; Moazed and Noller, 1989). To continue translation, the ribosome moves along the 
mRNA by one codon and the tRNAs translocate synchronously to the E site and P site. 
Translocation is a highly dynamic step and is greatly facilitated by the binding of the 
elongation factor G (EF-G) and hydrolysis of GTP (Rodnina and Wintermeyer, 2011). EF-G 
is able to bind to the ribosome independent of the formed tRNA state (Cornish et al., 
2008; Holtkamp et al., 2014; Sharma et al., 2016). The EF-G-catalyzed GTP hydrolysis 
results in a higher flexibility (unlocking) of the 30S subunit by inducing a conformational 
change. The higher flexibility leads to the relaxation of the ribosome interaction with the 
codon-anticodon complex allowing the ribosome to move along the mRNA (Belardinelli et 
al., 2016a; Rodnina et al., 1997; Savelsbergh et al., 2003). The ribosome is now occupied 
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by a peptidyl-tRNA in the P site, a deacylated tRNA in the E site from which it 
spontaneously dissociates, and a vacant A site displaying the next codon. 
 
Figure 2: Overview of the translation elongation cycle. 
The 30S IC is formed by binding of the initiator tRNA at the mRNA start codon in the P-site of 
the 30S subunit (dark grey), guided by the initiation factors 1, 2 & 3. The 70S initiation complex 
is formed by joining of the 50S (light grey) subunit and the 30S IC (Milon and Rodnina, 2012). 
Elongation encompasses the repetitive steps of decoding, peptide bond formation and 
translocation. In the first step EF-Tu*GTP delivers an aa-tRNA to the A site. Upon delivery, a 
new peptide bond between the polypeptide chain attached to the P-site tRNA and the amino 
acid of the A-site tRNA is formed. Binding of EF-G promotes translocation causing the tRNA to 
dissociate from the E site and creating a vacant A site, hence priming the ribosome for the next 
round of elongation. Upon translation of a sequence encoding multiple consecutive prolines 
(red background) translation comes to a halt on the second proline codon. The stalling is 
alleviated by the action of EF-P which facilitates peptide bond formation between the poor 
substrate Pro-tRNA
Pro 
(dark red) and other less reactive aminoacyl-tRNAs, allowing translation 
to continue. Nascent peptide, is released by binding of RF1 or RF2 to the stop codon displayed 
in the A site inducing the hydrolysis of the ester bond between the nascent chain and the tRNA. 
After termination, the 70S complex becomes disassembled by an orchestrated action of the 
ribosome recycling factor IF3 and EF-G. 
Introduction 
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Elongation is terminated by release factors that bind to the A site presenting a stop 
codon. Release factors distinguish their favored stop codons using a tripeptide motif in 
the respective factor, e.g., RF1 (PXT-tripeptide) reads the UAG and UAA stop codons, 
whereas RF2 (SPF-tripeptide) reads the UAG and UAA stop codons (Ito et al., 2000). Both 
RFs share a second functional tripeptide motif (GGQ), in which the Gln is in both cases 
post-translationally modified (Nakahigashi et al., 2002). The GGQ motif coordinates a 
water molecule in the PTC, resulting in the hydrolysis of the ester bond between the 
nascent chain and the tRNA (Dincbas-Renqvist et al., 2000; Shaw and Green, 2007; 
Weixlbaumer et al., 2008). The dissociation of RF1 and RF2 from the ribosome is 
facilitated by RF3 hydrolyzing GTP (Adio et al., 2018; Peske et al., 2014). The disassembly 
of resulting post-termination complex into free tRNA, mRNA and ribosomal subunits is 
orchestrated by the joined action of EF-G, the ribosome recycling factor (RRF) and IF3. 
EF-G together with RRF facilitate the dissociation of the ribosomal subunits, whilst IF3 
hinders their re-association (Peske et al., 2005) and serves as a bridging factor towards 
the next round of initiation (Milon and Rodnina, 2012). 
 
 Peptide bond formation 1.2
Peptide bond formation results from the nucleophilic attack of the α-amino moiety of the 
aa-tRNA on the carbonyl group of the esterified peptidyl-tRNA forming a tetrahedral 
adduct. The subsequent dissociation of the tetrahedral adduct results in the formation of 
the peptide bond. The new polypeptide-tRNA becomes longer by one amino acid and the 
P-site tRNA is deacylated. The ribosome-independent aminolysis reaction in solution is 
likely to proceed through two tetrahedral intermediates. The nucleophilic attack of the 
α-amino moiety results in the formation of a zwitterionic intermediate (T±), consisting of a 
secondary ammonium cation and an oxyanion. Subsequently, the secondary ammonium 
ion becomes deprotonated and forms the negatively charged second intermediate (T-) 
(Figure 3). The decomposition of the second intermediate results in the formation of the 
reaction products (Satterthwait and Jencks, 1974). Biochemical experiments (Dorner et 
al., 2003; Kuhlenkoetter et al., 2011; Weinger et al., 2004), structural studies (Schmeing et 
al., 2005) and molecular dynamic simulations (MDS) (Trobro and Aqvist, 2006; Wallin and 
Aqvist, 2010) suggested a proton-shuttle mechanism for the ribosome catalyzed reaction. 
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The proton of the attacking nucleophile is abstracted by the 2’-hydroxyl group and is 
shuttled to the 3’-hydroxyl group of the corresponding P-site tRNA. The proton-shuttle 
relies either on one or two additional water molecules, resulting in an 8-membered or 
10-member proton-shuttle, respectively (Kazemi et al., 2018; Rodnina, 2013). A structural 
study, suggested a second water molecule in close proximity to the ribosomal protein L27 
(Polikanov et al., 2014). Interestingly computational simulations suggested that both 
shuttle models are in agreement with previous kinetic solvent isotope effect studies (KSIE) 
for peptide bond formation (Kazemi et al., 2018; Kuhlenkoetter et al., 2011). A 
heavy-atom kinetic isotope effects (KIE) analysis revealed that the breakdown of the 
tetrahedral intermediate is not part of the rate-limiting step, unlike its formation and the 
proton transfer from the attacking nitrogen (Hiller et al., 2011). The function of the 
ribosome is to lower the activation entropy and change the rate limiting transition state 
(reviewed in: (Rodnina, 2013). 
 
Figure 3: Comparison of peptide bond formation in solution and catalyzed by the ribosome. 
A) P-site peptidyl-tRNA and A-site aa-tRNA depicted prior to peptidyl transfer in solution, with 
the imminent nucleophilic attack indicated by an arrow. 
B) The top-raw depicts the proposed transition states (T± and T-) of the in-solution reaction, 
whereas the bottom raw shows the ribosome catalyzed-reaction with a concerted 8-member 
proton shuttle. 
C) P-site deacylated tRNA and the newly formed A-site peptidyl-tRNA after peptide bond 
formation. 
 
The catalysis of peptide bond formation by the ribosome is not restricted to L-amino 
acids, but also allows some D-amino acids and a broad spectrum of unnatural amino acids 
as substrates (Fujino et al., 2013; Katoh and Suga, 2018; Kawakami and Murakami, 2012; 
Liu and Schultz, 2010). Considering the limited variety of potential functional moieties 
available in the peptidyl-transferase center, which is formed by the 23S rRNA only, the 
spectrum of substrates is broad and versatile. The rate of peptide bond formation across 
the 20 canonical amino acids is rather uniform, with few exceptions such as proline. The 
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9 
substrates do show different reaction rates with puromycin, an aminonucleoside 
antibiotic that resembles the CCA-end of a tRNA and therefore serves as acceptor of the 
nascent chain. The uniformity of peptide bond formation is achieved by having a 
preceding rate limiting step, the accommodation of the A-site tRNA (Ledoux and 
Uhlenbeck, 2008; Wohlgemuth et al., 2008), with very few exceptions and proline being 
one of them (Pavlov et al., 2009). 
In addition to catalysis of peptide bond formation, the ribosome can facilitate the 
formation of esters, thioesters, thioamides or phosphinoamides (Bieling et al., 2006; 
Fahnestock et al., 1970; Lieberman and Dahlberg, 1995; Victorova et al., 1976). Hence, 
the ribosome can be considered as a versatile catalyst. 
 
 Elongation factor P 1.3
1.3.1 Amino acid proline  
Although the rates for peptide bond formation during translation are in most cases 
uniform, the rate of translation in the cell can vary substantially. The translation rate is 
influenced by the abundance of tRNAs, secondary structures of the mRNA or the nature 
of the amino acids to be incorporated into the growing nascent chain (Bullwinkle and 
Ibba, 2016; Moine et al., 1988; Pavlov et al., 2009; Yanofsky and Horn, 1994). The nature 
of the amino acids that react in the PTC to form a peptide bond can slow down and in 
special cases cause stalling of translation (Ito et al., 2011). Upon translation of 
consecutively encoded prolines, the ribosome is stalled, as proline is a poor donor and a 
poor acceptor in peptidyl transfer (Doerfel et al., 2013; Muto and Ito, 2008; Wohlgemuth 
et al., 2008). The pyrrolidine ring of proline that spans the α-carbon and amino group 
restricts the N-Cα bond torsion angles to φ = -63 and ψ= -75, thus limiting the number of 
accessible conformations (Hovmoller et al., 2002). Proline also restricts the backbone 
conformation of the neighboring residues (MacArthur and Thornton, 1991). The 
pyrrolidine ring can adopt two distinct conformations with Cγ in an endo- (pointing 
towards Cα) or exo-conformation (pointing away from Cα)(Ramachandran et al., 1970). As 
other proteinogenic amino acids, proline can adopt two distinct isoforms, cis or trans. 
While other amino acid sterically favor trans-conformations, proline has nearly no 
thermodynamic hindrance for a cis-trans-isomerization (G ~0.7 kcal/mol of difference) 
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(Owens et al., 2007). The isomerization is, however, so slow and kinetically unfavorable 
(Fischer et al., 1994), that less than 10% amino acid-proline bonds in proteins adopt a 
cis-conformation (reviewed in: (Yaron and Naider, 1993)). 
 
Figure 4: Steric properties of proline. 
A) Trans-cis isomerization of proline, with R and X representing the preceding and the following 
amino acid residues. 
B) Stereoisomers of proline in the endo- and exo-conformation. 
Figure adopted from: (Doerfel et al., 2015). 
 
These characteristics make proline a special amino acid that plays specific roles in 
proteins. Because proline is sterically restricted and has a limited ability to form hydrogen 
bonds, it is usually only found in the first turns of α-helices (MacArthur and Thornton, 
1991; Woolfson and Williams, 1990) and bulges or sheet edges of ß-sheets, where no 
hydrogen bond donor is required (Li et al., 1996). When located in an α-helix, proline can 
affect the overall structure of the protein. Proline introduces a kink into the secondary 
structure, which, because of prolines rigidity can translate into the tertiary structure 
(Barlow and Thornton, 1988). Hence, prolines are frequently found in irregular structures 
such as α-helical capping motifs, β-turns, poly(Pro)- and collagen-helices (Bhattacharyya 
and Chakrabarti, 2003; Chakrabarti and Pal, 2001; MacArthur and Thornton, 1991). The 
puckering of proline’s pyrrolidine ring allows it to tune the stability of the secondary 
structure, as demonstrated e.g. for collagen-helices (Vitagliano et al., 2001). The 
cis-trans-isomerization of proline in proteins can confer to a hinge like function, allowing 
major conformational changes of folded proteins. This mechanism was reported for the 
opening of channels (Lummis et al., 2005), isomer-dependent dimerization (Jenko Kokalj 
et al., 2007; Solbak et al., 2010), membrane binding (Evans and Nelsestuen, 1996) and 
auto-inhibition control (Sarkar et al., 2007). Cis-trans-isomerization occurs slowly and was 




During peptide bond formation proline is a particular poor substrate, as donor as well 
as acceptor. The resulting slow peptide bond formation becomes an obstacle for the 
translation of poly(Pro) sequences. The reaction between the peptidyl-Pro-Pro-tRNA in 
the P site and the Pro-tRNA in the A site is slowed down to an extend that translational 
stalling occurs. In bacteria the translational stalling caused by a strung of prolines is 
alleviated by elongation factor P (EF-P) (Doerfel et al., 2013; Ude et al., 2013). Because 
poly(Pro) sequences are ubiquitous, homologs of EF-P are found in eukaryotes (eIF5a) and 
archaea (aIF5a). One of these poly(Pro)-containing proteins is the valine tRNA 
synthetase (ValS), which was found in genomes of over 1200 bacterial, 205 archaeal and 
nearly 100 eukaryotes (Starosta et al., 2014b). The proline-triplet of ValS is located in the 
active center. It is essential for efficient Val-tRNAVal charging and prevents mischarging of 
tRNAVal with threonine (Fukai et al., 2000; Fukai et al., 2003). As the valS gene is essential 
for cell viability and the presence of EF-P is a prerequisite for efficient valS translation, it 
has been suggested that both proteins co-evolved (Baba et al., 2006; Starosta et al., 
2014b). 
 
1.3.2 Function and biological relevance of EF-P 
EF-P was initially identified by its ability to increase the product yield of an fM-puromycin 
reaction (Glick and Ganoza, 1975). Shortly after, EF-P was reported to enhance the 
peptidyl-transferase activity for glycine, stimulate poly(Phe)/(Lys) product formation and 
the translation of a naturally occurring mRNA (Aoki et al., 1997; Aoki et al., 2008; Ganoza 
et al., 1985; Glick et al., 1979; Glick and Ganoza, 1975; Green et al., 1985). However, these 
reported effects were small and did not exceed a factor of 2-fold. Based on a structural 
study and the described biochemical insights, it was proposed that EF-P either positions 
the tRNAfMet in a productive conformation in the P-site (Aoki et al., 2008; Blaha et al., 
2009) or facilitates the initial peptide bond formation (Aoki et al., 2008; Blaha et al., 
2009). Two research groups simultaneously elucidated the functional context of EF-P 
(Doerfel et al., 2013; Ude et al., 2013). Doerfel, Wohlgemuth and colleagues used a fully 
reconstituted in vitro translation system to calculate the reaction rates between different 




Figure 5: EF-P facilitates synthesis of poly-proline and PPG-containing peptides. 
A) Translation of AmiB containing a poly(Pro) sequence in the absence (left side) or presence of 
EF-P (right side). 
B & C) Formation of a model peptide in a fully reconstituted in vitro translation system in the 
absence (white circles) or presence of EF-P (black circles). 
D) Contribution of EF-P K34 modification to the formation of fMPPG peptide in a fully 
reconstituted in vitro translation system. Reaction facilitated by: unmodified EF-P (open 
squares), overexpressed lysinylated but unhydroxylated EF-P (solid triangles), and 
lysinylated/hydroxylated overexpressed EF-P (solid circles), native EF-P (open triangles) or no 
EF-P (open circles). 
(Figures adopted from: (Doerfel et al., 2013)) 
 
They found that for most P-site amino acids EF-P stimulated the puromycin reactions by 
only about 5-fold, except with fMP with which the reaction was accelerate 90-fold. Similar 
effects were observed for the incorporation of different aa-tRNA A site substrates. The 
formation of di-peptides was, however, accelerated to a smaller extend. For most 
combinations, EF-P facilitates peptide bond formation 2-fold. However, for poorly 
reactive substrates like glycine or proline larger effects were observed, 8-fold and 16-fold, 
respectively. Longer poly(Pro) model peptides (e.g. fMPPG or fMPPPF) were not 
synthesized in the absence of EF-P. Interestingly, the amino acid after the PP sequence 
also has an impact on the translation efficiency (Figure 5: B vs C). Later experiments have 
confirmed this notion and have shown that also the downstream amino acid can affect 
translation efficiency. This allows to group amino acid sequences into strong stallers (PPP, 
DPP or PPN) or weak stallers (CPP, PPR or PPH) (Doerfel et al., 2013; Peil et al., 2013; 
Starosta et al., 2014a; Ude et al., 2013). Using natural, substantially longer mRNA 
sequences in the in vitro translation system led to similar results: translation of the AmiB 
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fragment (159 aa), which contains eight consecutive prolines, was negligible in the 
absence of EF-P, but very efficient when EF-P was added (Figure 5A). Residue lysine 34 of 
EF-P is post-translational modified to (R)-β-lysylhydroxylysine (Navarre et al., 2010; Peil et 
al., 2012; Roy et al., 2011; Yanagisawa et al., 2010) and the modification is important for 
EF-P function (Figure 5D). Overexpressed lysinylated/hydroxylated, lysinylated, but not 
hydroxylated, and native EF-P have similar activity. Unmodified EF-P showed a 
significantly reduced activity, whereas without EF-P nearly no product formation was 
observed (Doerfel et al., 2013). In addition to unmodified EF-P, Ude and co-workers 
created the EF-P variant K34A, which cannot be modified. In their in vitro translation 
system unmodified EF-P and EF-P K34A showed no activity, and yielded the same readout 
as a reaction without EF-P (Ude et al., 2013). Thus, the presence of EF-P and its 
post-translational modification is indispensable for synthesis of poly(Pro) containing 
proteins (Doerfel et al., 2013; Peil et al., 2013; Ude et al., 2013). 
Apart from facilitating peptide bond formation, EF-P was also reported to stabilize the 
P-site peptidyl-tRNA (Doerfel et al., 2013). This was reflected in higher product yields 
resulting from a reduced drop-off of peptidyl-tRNA from the ribosome. The stabilizing 
effect of EF-P on the peptidyl-tRNA was further supported by a cryo-electron microscopic 
study, which reported a high abundance of vacant ribosomes in the absence of EF-P 
(Huter et al., 2017). 
As described in chapter 1.2 the ribosome can incorporate some D-amino acid into a 
growing nascent chain, but incorporation of several consecutive D-amino acids was 
described to be almost impossible. Because EF-P can facilitated peptide bond formation 
and resolve stalling resulting from the consecutive incorporation of L-Pro, it was 
suggested that EF-P could facilitated peptide bond formation for D-amino acids. Indeed, 
EF-P was reported to increase the relative poly-D-Phe yield from 1 to 10% (Huang, 2017). 
However, the proposed mechanism of EF-P binding to the D-amino acid containing P-site 
peptidyl-tRNA and subsequent facilitation of peptide bond formation, is in disagreement 
with (Katoh et al., 2016). Katoh and co-workers could show that the presence of the 
tRNAPro D-arm architecture is a requisite for EF-Ps activity, whereas Huang and co-workers 
used a tRNAGlu2. Furthermore, EF-P-facilitated poly-D-Phe synthesis failed to be 
reproduced in a later study (Katoh et al., 2017a), supporting the relevance of the tRNA 
D-arm. Optimization of the reaction conditions resulted in an increased incorporation of 
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consecutive D-amino acids by as much as 5-fold in the absence of EF-P (Katoh et al., 
2017b). To further improve the efficiency of D-amino acids incorporation, the D-arms of 
their respective tRNAs were engineered to be recognized by EF-P, which improved the 
yield by as much as 10-fold (Katoh et al., 2017a). The same approach was recently used to 
achieve the consecutive incorporation of β-amino acids for the first time (Katoh and Suga, 
2018). These finding indicate a potential of EF-P for biotechnological and pharmaceutical 
applications, which would allow the more efficient synthesis of peptides containing 
non-proteinogenic amino acids. 
The relevance of EF-P was also shown in in vivo studies. Despite EF-Ps crucial function 
in translation, addition functions have been reported. EF-P was proposed to ensure the 
coupling of the translating ribosome to the transcribing RNA polymerases by preventing 
ribosome stalling induced by poly(Pro) sequences (Elgamal et al., 2016). Hence, EF-P can 
not only regulate protein biosynthesis on the translational level, but also indirectly on a 
transcriptional level. However, the number of genes that require EF-P for maintaining the 
coupling of transcription and translation appears to be rather low (reviewed in: (Rajkovic 
and Ibba, 2017)). Furthermore, EF-P was reported to prevent frameshifting. In the 
absence of EF-P, spontaneous frameshifting was increased 3-fold in vivo (Gamper et al., 
2015). However, it was neglected that Δefp variants in general showed a 2- to 3-fold 
reduced translation capacity (Hersch et al., 2013). In vitro experiments in the absence of 
EF-P suggested a 30-fold increase in frameshifting efficiency (Gamper et al., 2015). Such 
acceleration of a proline independent reaction by EF-P, is however, in conflict with 
previously reported rates (Doerfel et al., 2013). 
Interestingly, EF-P does not seem to be essential for many bacteria. In E. coli it 
appears to be conditionally essential, since both cases have been reported (Aoki et al., 
1997; Baba et al., 2006; Gerdes et al., 2003; Joyce et al., 2006; Peil et al., 2013; Peil et al., 
2012; Yamamoto et al., 2009). For many other bacteria, e.g. Bacillus, Salmonella, Shigella, 
Pseudomas, Agrobacterium or Acinetobacter, EF-P is not essential for cell viability (Balibar 
et al., 2013; de Crecy et al., 2007; Langridge et al., 2009; Peng et al., 2001). However, 
upon deletion of the efp gene or genes encoding the post-translational modifying 
enzymes, severe phenotypes can be observed (Abratt et al., 1998; Van Dyk et al., 1987). In 
addition, many pathogenic bacteria become significantly less or avirulent. Variants (efp, 
epmA and epmB) of different Salmonella species showed a hyper-susceptibility towards 
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low osmolality, various antibiotics, an attenuated virulence and reduced migration 
abilities, resulting from perturbations in the cell envelop (Bearson et al., 2011; Block et al., 
2010; Choi et al., 2018; Hersch et al., 2013; Kaniga et al., 1998; Navarre et al., 2010; Zou et 
al., 2012). Shigella flexneri poxA and efp variants showed an impaired ability to form 
plagues or invade the host epithelial cells. Interestingly, not only virulence proteins were 
found to be reduced, but also the mRNA level of a master regulator of virulence were 
lower (Marman et al., 2014). Brucella aboruts variants lacking EF-P failed to invade their 
host cells (Iannino et al., 2012). Neisseria meningitidis appears to require rhamonslyated 
EF-P for its cell viability (Yanagisawa et al., 2016). Aside from human pathogens, also plant 
pathogens show reduced virulence and higher susceptibility upon deletion of EF-P and its 
modifying enzymes. Deleting the EF-P homolog encoded by chvH in the plant pathogen 
A. thumefaciens produced variants defective in plant virulence (Charles and Nester, 
1993). In Erwinia amylovora the deletion of epmB is sufficient to cause a reduced 
virulence and an increased chemical sensibility (Klee et al., 2018). The reduction of 
pathogenicity and increased stress susceptibility, in bacteria with an impaired EF-P 
activity, makes EF-P and its modifying enzymes to a putative drug target. Because the 
analogous system in higher eukaryotes is highly specific, it is unlikely to be targeted by an 
inhibitor of the bacterial system. Taken together, these findings make EF-P and its 
modifying enzymes a promising target to develop novel antimicrobials. 
 
1.3.3 Structure of elongation factor P 
EF-P consists of three domains resembling the L-shape of tRNAs (Figure 6A & B). It has an 
overall negative net charge, except for the tip of domain I (Hanawa-Suetsugu et al., 2004). 
The eukaryotic and archaeal initiation factor 5A (eIF5A and aIF5A) are homologs of EF-P. 
eIF5A and aIF5A adopted a two domain structure and lack the bacterial specific domain 
III. Overall, the eukaryotic and archaeal EF-P homologs show a significant structural 




Figure 6: Structural comparison of EF-P, tRNA, eIF5A and aIF5A. 
A) E. coli EF-P obtained by cryo-electron microscopy [6ENU] (Huter et al., 2017) with domains 
indicated as domain I (DI), domain II (DII) and domain III (DIII). 
B) E. coli tRNA
Pro1
 obtained by cryo-electron microscopy [6ENU] (Huter et al., 2017). 
C) Human eIF5A obtained by X-ray crystallographic [3CPF] (Tong et al., 2009b). Labeling as A. 
D) Methanocaldococcus jannaschii aIF5A obtained by X-ray crystallographic [1EIF] (Kim et al., 
1998). Labeling as for A. 
E) Superposition of domains I of E. coli EF-P and human eIF5A. 
 
The N-terminal domain I of EF-P comprises a ß-barrel fold comprising 6 ß-strands and a 
flexible loop (loop I) at the tip. In E. coli loop I of domain I is conserved and contains lysine 
residue 34, which is post-translationally modified. The modification of K34 by 
R-(β)-lysinylation, which is crucial for the function of EF-P, is located at the tip of the loop I 
extending away from the domain body. Crystallographic studies indicate a great flexibility 
of the linkage between domain I and domain II. Domain II is formed by a ß-barrel with 
7 β-strands. It has an oligonucleotide-binding fold, as found in RNA-binding proteins 
(Blaha et al., 2009; Hanawa-Suetsugu et al., 2004). The link between domain II and 
domain III appears, compared to domain I – domain II linkage, relative rigid (Choi and 
Choe, 2011). In EF-P domain III is structurally similar to domain II. The overall domain 
arrangement mimics the L-shape of a tRNA. A potential key feature of domain III is the 
flexible loop I containing a conserved GDT motif (Huter et al., 2017). Domain III is specific 
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for bacteria and hence lacking in eIF5A and aIF5A. The N-terminal domain of aIF5A and 
eIF5A topologically coincides with EF-P domain I (Figure 6E). Interestingly, the C-terminal 
domain of a/eIF5A is similar to the N-terminal half of EF-P domain II and the C-terminal 
half of EF-P domain III (Blaha et al., 2009). EF-P domain III appears to originate from a 
duplication of EF-P domain II. However, the evolutionary origin of EF-P domain III and the 
C-terminal domain of aIF5A/eIF5A is yet not fully understood (Hanawa-Suetsugu et al., 
2004). 
 
1.3.4 Post-translational modification of EF-P 
The post-translational modification of EF-P K34 was initially recognized by a mass shift 
of +144 Da (Aoki et al., 2008). Genetic studies suggested a post-translation modification 
of K34 by (R)‐β‐lysine (+128 Da) required two enzymes, EpmA and EpmB (Figure 7A) 
(Bailly and de Crecy-Lagard, 2010). First, the lysine 2,3-aminomutase (EpmB, also referred 
to as YjeK) transforms (S)-α-lysine into (R)-β-lysine (Behshad et al., 2006; Roy et al., 2011). 
Second, the Elongation factor P-(R)-β-lysine ligase (EpmA, also referred to as GenX, PoxA 
and YjeA) ligates (R)-β-lysine to EF-P K34 in an ATP-dependent manner. This mechanism 
was confirmed by genetic (Ambrogelly et al., 2010; Navarre et al., 2010) and structural 
work (Sumida et al., 2010), and by biochemical in vitro assays (Yanagisawa et al., 2010). 
EpmA evolved from a class II amino acyl tRNA synthetase (aaRS) which lost its anticodon 
binding domain, gained an EF-P specificity and has a broad substrate spectrum (Bailly and 
de Crecy-Lagard, 2010; Katz et al., 2014; Navarre et al., 2010; Yanagisawa et al., 2010). In 
addition to the target substrate, (R)-β-lysine, in vivo studies showed that EpmA can 
equally well utilize the enantiomer (S)-β-lysine, which in fact leads to an activated EF-P 
(Gilreath et al., 2011; Roy et al., 2011). In addition, in an in-vitro assay also the 
constitutional isomer (L)-α-lysine was accepted and ligated to K34 of EF-P. However, the 
α-lysinylated EF-P is inactive (Gilreath et al., 2011; Roy et al., 2011). Notably, in a 
substrate competition assay (R)‐β‐lysine (KM = 213 µM) is highly favored over its α‐lysine 
constitutional isomer (KM = 8600 µM) and its enantiomer (KM = 6950 µM) (Roy et al., 
2011). The discrepancy of +16 Da between the mass shift +144 Da and +128 Da by 
(R)-β-lysine corresponds to the addition of a single oxygen atom, likely, in the form of a 
hydroxyl moiety. Elogation factor P hydroxylase (EpmC, also referred to as YfcM) was 
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reported to hydroxylate K34 of EF-P. YfcM binds only lysinylated EF-P and modifies it at 
the δ-C5 of K34 (Kobayashi et al., 2014a; Kobayashi et al., 2014b; Peil et al., 2012). 
Because EF-P is universally conserved and its modification is of key functional 
importance (Doerfel et al., 2013; Navarre et al., 2010; Ude et al., 2013; Yanagisawa et al., 
2010), it is surprising that only 22% of all sequenced bacterial genomes encode orthologs 
of EpmA or EpmB (Bailly and de Crecy-Lagard, 2010; Lassak et al., 2015). A phylogentic 
analysis revealed that in 9% of all sequenced bacterial genomes, a conserved arginine 
residue (R32) is found in a position equivalent to K34 (Choi and Choe, 2011; Lassak et al., 
2015). In Shewanella oneidenis, an EF-P R32 modifying enzyme was identified. The EF-P 
R32 rhamnosyl-transferase (EarP) uses dTDP-β-(L)-rhamnose as a substrate; the 
modification of EF-P R32 with rhamnosylation was confirmed by mass-spectrometry 
(Figure 7B) (Lassak et al., 2015; Wang et al., 2017). Anti-R32-rhamanosyl antibodies and 
crystallographic studies confirmed the EF-P-EarP interactions in multiple bacterial strains 
(Krafczyk et al., 2017; Li et al., 2016; Sengoku et al., 2018). In contrast to the EF-P 
lysinylation mechanism, the usage of dTDP-(L)-rhamnose competes with many other 
intracellular biosynthetic pathways (Babaoglu et al., 2003; Lam et al., 2011; Lindhout et 
al., 2009; Rahim et al., 2001; Schirm et al., 2004). Therefore, the flow and the availability 
of substrate has to be under tight regulation to ensure the efficient modification of 




Figure 7: Post-translational modification of EF-P. 
A) E. coli EF-P residue K34 modified to ε(R)-β-lysylhydroxylysine by action of EpmA and C. 
B) S. oneidenis EF-P rhamnosylated at residue R32 by EarP. 
 
The described bacterial EF-P post-translational modification machineries can only be 
found in 31% of all sequenced bacterial genomes and mainly in genomes of 
Gram-negative bacteria. Recently the post-translational modification of EF-P in the 
Gram-positive model organism Bacillus subtilis was identified. The modification of K32 
with 5-aminopentanol showed a positive impact on the translation of poly(Pro) containing 
proteins. In B. subtilis EF-P-dependent peptide sequences were mainly found in flagellar 
genes; deletion of EF-P caused a reduced swarming motility. Initially reported sporulation 
failures (Meeske et al., 2016; Ohashi et al., 2003), could not be restored by 
complementation studies. In contrast to the previously described modification, the genes 
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encoding the modification enzymes were not found in the direct neighborhood to the 
EF-P gene (Rajkovic et al., 2016), which makes it much harder to identify putative 
modifying enzyme from a genetic screening. The B. subtilis EF-P modifying enzymes Ymfl 
was shown to catalyze the reduction of 5-aminopentanone to 5-aminopentanol. 
Interestingly, a 5-aminopenatnone modified EF-P appear to be biochemically inactive, 
whereas the unmodified EF-P remained active (Hummels et al., 2017). A genetic screen 
revealed two other genes (ynbB and gsaB) involved in the modification, however, their 
direct contribution to a distinct modification step could not be assigned yet. In the 
corresponding deletion strains K32 was acetylated instead of modified to 
5-aminopentanol. Furthermore, three genes (yaaO, yfkA and ywlG) were identified which 
influence the degree of EF-P K32 modification, however, their mode of action remains to 
be elucidated (Witzky et al., 2018). The following modification pathway was suggest: K32 
becomes modified with hydroxypentanone, which in turns becomes dehydrate and forms 
pentanone, which is converted to 5-aminopentanone by a hydroamination reaction, and 
reduced to 5-aminopentanol by Ymfl (Witzky et al., 2018). B. subtilis was reported to tune 
the activity of EF-P, although the mechanism is not yet fully understood. The deletion of 
EF-P in B. subtilis causes a reduced swarming motility, which is in line with the occurrence 
of poly(Pro) sequences in genes related to cell motility. The lack of a severe phenotype 
correlates with the general low abundance of poly(Pro) sequences in the B. subtilis 
genome. It was proposed that for bacteria with a high abundance of poly(Pro) sequences 
in their genome, EF-P is more important than in those with a low abundance of poly(Pro) 
sequences. Overall, the nature of many post-translational modifications of EF-P is yet not 
described. It still remains unknown whether other factors can perform similar task or 
compensate for the lack of EF-P. Organism with either no or two copies of EF-P have been 
reported, but the functional significance of these findings remains unclear (reviewed in: 
(Lassak et al., 2016)). For some gammaproteobacteria, such as E. coli or Vibrio cholera, an 
EFP-like protein (YeiP) was described as a paralog of EF-P (Richards et al., 2012). Whether 
it binds to the ribosome or can compensate for the lack of EF-P remains to be elucidated. 
 
1.3.5 EF-P interaction partners 
EF-P binds in an equimolar ratio to the ribosome. The binding site spans both subunits 
and is located between the P and E sites (Aoki et al., 2008; Blaha et al., 2009; Huter et al., 
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2017). For most crystallographic studies, the ribosomes and EF-P used for crystallization 
were from different organisms and none of the complexes was stalled by a PPP sequence 
or contained a prolyl-nascent chain in the P site. However, a recent study combined 
cryo-electron microscopic structures with molecular dynamic simulations and biochemical 
insights on poly(Pro) stalled E. coli ribosomes containing post-translational modified 
E. coli EF-P (Huter et al., 2017). 
In the structure, domain III of EF-P interacted with the 30S subunit and mRNA, as well 
as with the P-site tRNA via the EF-P residues Y183 and R186 (Blaha et al., 2009). Replacing 
one of the residues with alanine (Y183A or R186A) caused the complete loss of EF-P 
function. Both residues are highly conserved across bacterial EF-P sequences (Huter et al., 
2017). The conserved GDT motif in loop I (amino acids 144-146) in the C-terminal domain 
III is well resolved. EF-P was found to bind to the β-hairpin of S7 and cause a 
conformational change and shift of S7 by 7.4 Å (Figure 8A). The shift positions the EF-P 
residues D145 and T146 in such a way that they could form hydrogen bonds with the 
mRNA E-site codon (Figure 8B). The potential significance of the mRNA E-site codon for 
EF-P binding was further strengthened by molecular dynamic simulations (MDS). A 
mechanism of mRNA E-site codon reading by EF-P was proposed, which is analogous to 
the stop codon reading by release factor 1 and 2 using SPF and PXT motifs (Huter et al., 
2017; Zhou et al., 2012). Molecular dynamic simulations suggest that EF-P could sense the 
first two bases of the E-site codon and that the nature of the mRNA bases could influence 
the binding of EF-P. Upon accommodation of EF-P all purines bases would cause steric 
clashes (AAA and GGG codons) and hinder EF-P binding, whereas pyrimidine derivatives 
allow either less stable (UUU) or stable (CCX) accommodation of EF-P in the E site (Huter 
et al., 2017). This hypothesis is supported by the fact that proline codons contain 
pyrimidine bases in position 1 and 2: CCG (55% codon-usage in E. coli), CCA (20%), 
CCU (15%) and CCC (10%) (Maloy et al., 1996). The absence of domain III in the eukaryotic 
and archaeal EF-P homologue argues against the importance of the E-site interactions. On 
the other hand, eIF5A was reported to be beneficial for translation independent of 
poly(Pro) stalling motifs (Pelechano and Alepuz, 2017; Schuller et al., 2017). The lack of 
domain III in eIF5A may explain its broader substrate spectrum, while EF-P binding is 
dependent on the E-site codon, supporting the high context specificity of EF-P. This 
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evidence suggests that the interactions of EF-P with the E site are important, but this has 
not been tested biochemically. 
EF-P domain II interacts with the ribosomal protein L1 and is sandwiched between L1 
domain I and II (Figure 8C) (Blaha et al., 2009; Huter et al., 2017). The L1 stalk is a highly 
dynamic structure which consists of 23S rRNA and the ribosomal protein L1 (Yusupov et 
al., 2001). Upon interacting with EF-P the L1 stalk adopts a closed conformation (Blaha et 
al., 2009). Such a closed conformation was previously reported for L1 interacting with a 
deacylated-tRNA in a P/E hybrid state, in which the exit of the E site is occupied by the L1 
stalk (Chen et al., 2013; Cornish et al., 2009; Fu et al., 2011; Tourigny et al., 2013; Valle et 
al., 2003). The positively charged surface of L1 interacts with the negatively charged 
surface of EF-P, similarly to the L1-tRNA interaction. These interactions may help to 
release the deacylated tRNAs from the E site (Bock et al., 2013; Munro et al., 2010; 
Selmer et al., 2006; Yusupov et al., 2001). For eIF5A a similar conformation was described, 
which is supported by the results of hydroxyl radical probing experiments (Gutierrez et 





Figure 8: Interaction of EF-P with the mRNA, P-site tRNA and ribosomal protein L1. 
A) EF-P-induced shift of the ribosomal protein S7 (turquoise vs ochre) and the position of the 
EF-P domain III (d3) loop I. Residues G144, D145, and T146 of EF-P may interact with the E-site 
mRNA codon. 
B) Potential hydrogen bonds between EF-P d3 loop I with S7 and with the mRNA. Hydrogen 
bonds are shown as yellow dashed lines. 
C) Top view on the interaction of EF-P with the P-site tRNA and the ribosomal protein L1. 
Figures A and B are modified from, and C is based on [6ENU](Huter et al., 2017). 
 
Domain II of EF-P interacts with the D-arm of the P-site tRNA. EF-P is sensitive to the 
geometry of the tRNA D-arm, determined by its stability and the lengths of the stem arm. 
Alternation of the D-arm while remaining the original tRNAPro body abolished the ability of 
EF-P to facilitate catalysis (Katoh et al., 2016). Interestingly, only tRNAPro isoacceptors and 
the initiator tRNAfMet share the same D arm geometry and are the only reported 
substrates of EF-P (Doerfel et al., 2013; Glick et al., 1979; Glick and Ganoza, 1975; Ude et 
al., 2013). In E. coli and T. thermophiles EF-P residue D69 interacts with U17a of the D-arm 
of the P-site tRNA (Blaha et al., 2009; Huter et al., 2017). In yeast no analogous interaction 
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was reported (Melnikov et al., 2016; Schmidt et al., 2016b), which further supports the 
less defined substrate spectrum of eIF5a. 
Another important patch of EF-P is located within the positively charged region 
domain I, which provides an interaction hub with the 23S rRNA of the PTC, the acceptor-
stem and CCA-end of the P-site tRNA (Figure 8C) (Hanawa-Suetsugu et al., 2004; Huter et 
al., 2017). The domain I contains a conserved P-loop which is important for EF-Ps 
functionality. The key residue is K34 located in the P-loop of domain I. K34 is 
post-translationally modified by R-lysinylation and hydroxylation (Yanagisawa et al., 
2010). Similar modifications of EF-P at homologous positons were reported for other 
bacterial EF-Ps, aIF5A and eIF5A (section: 1.3.4 and 1.3.7). Overall, the interactions of 
modified E. coli EF-P, unmodified T. thermophilus EF-P and hypusinylated eIF5A from 
yeast with the CCA-end of the P-site peptidyl-tRNA are very similar (Figure 9). 
 
Figure 9: Comparison of E. coli EF-P and its homologues interacting with the P-site tRNA CCA-end. 
A) E. coli EF-P bound to the ribosome. Potential hydrogen bonds between the post-
translationally added ε(R)-β-lysyl-hydroxylysine with the CCA-end of the peptidyl-tRNA are 
indicated as yellow dashed lines. 
B) T. thermophiles EF-P bound to the ribosome superimposed on A. Different positioning of 
both EF-P molecules is indicated by the distance of the shift. 
C) Yeast eIF5A bound to the ribosome superimposed on A. The post-translational modifications 
of EF-P and eIF5A extend into the PTC nearly to a similar degree. The conformation and 
resulting interaction are however distinctly different. 
(Figure adapted from: (Huter et al., 2017)) 
 
The ε(R)-β-lysylhydroxylysine 34 of E. coli extends deep into a crevice adjacent to the 
CCA-end. Its β-hydroxyl moiety is in hydrogen bonding distance with A76 and the 
ε-terminal (R)-lysyl amino moiety is in hydrogen bonding distance with the 2’OH of C75s 
ribose (Figure 9A). These backbone interactions stabilize the CCA-end and the P-site tRNA. 
In addition, an interaction between the post-translational modification of EF-P and the 
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conserved nucleotide A2439 of the 23S rRNA was reported. For eIF5A analogous 
interactions were proposed (Figure 9C). The unmodified T. thermophilus EF-P extends less 
deep into the PTC and only showed interactions with C75 (Figure 9B) (Huter et al., 2017). 
The stabilization of the P-site peptidyl-tRNA by EF-P translates into the stabilization of 
the nascent chain. This conclusion was drawn from an increased density of the nascent 
chain during cryo-electron microscopy measurements. However, local resolution 
calculation on the nascent chain allowed only the modeling of four C-terminal residues, 
indicating that the rest of the nascent chain remains flexible. The two C-terminal prolines 
did not adopt an all-trans, nor an all-cis conformation. An all-trans conformation of 
Pro-Pro is found in di-prolyl-containing proteins, such as ribosomal protein S11 or L11, 
and in type II poly(Pro) helices (Fischer et al., 2015). Such conformation in a nascent-chain 
would cause steric clashes between the -2 residue of the nascent chain and nucleotide 
G2061 of the 23S rRNA. An all-cis di-prolyl conformation would drive the nascent-chain 
towards the A site and cause a steric clash with the ribosome. Instead, in the presence of 
modified EF-P Pro-Pro adopts an alternative trans-conformation. However, in order to 
obtain a detailed description of the diasteromer conformation, a better resolved structure 
is required. This unusual conformation allows the nascent chain to evade G2061 and to 
extend into the ribosomal exit tunnel. A similarly unusual Pro-Pro conformation was 
reported for the CMV-stalling peptidyl-tRNA (Matheisl et al., 2015). The overall position of 
the nascent chain corresponds to stalled peptidyl-tRNAs as found in SecM (Zhang et al., 
2015), MifM (Sohmen et al., 2015) and VemP (Su et al., 2017). These insights suggest that 
the di-prolyl nascent chain cannot adopt its favored conformation, resulting in the 
induction of an energetically metastable conformation, which in turn causes the 
destabilization of the P-site peptidyl-tRNA and ultimately ribosomal stalling. Binding of 
EF-P, however, stabilizes the P-site peptidyl-tRNA and conducts the nascent chain into a 
conformation allowing peptide bond formation to occur and thereby restores translation. 
 
1.3.6 Eukaryotic homologue eIF5A 
eIF5A is a homolog of the bacterial EF-P. Similarly to EF-P, eIF5A is post-translationally 
modified, but the modification is different. eIF5A is uniquely post-translationally modified 
with the non-canonical amino acid hypusine (Cooper et al., 1983; Folk et al., 1980; Park et 
al., 1981, 1982). It’s the post-translational modification is critical for the function of eIF5A 
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(Benne and Hershey, 1978; Gutierrez et al., 2013; Park et al., 2011; Park, 1989; Park et al., 
1991; Saini et al., 2009; Schreier et al., 1977). In contrast to EF-P, unmodified eIF5A 
stimulates the fM-Pmn reaction 10-fold, whereas modified eIF5A enhanced the reaction 
by more than 100-fold. Analogously to EF-P, eIF5A alleviates poly(Pro) stalling. 
Interestingly, ribosome-profiling experiments revealed that in the absence of eIF5A 
ribosomes were stalled not only at the proline runs, but also at non-poly(Pro) tri-peptide 
sequences. This indicates a broader functional context of eIF5A in comparison to EF-P 
(Schuller et al., 2017). The ability to facilitate a variety of stalling-motifs might be 
explained by the lack of interactions between eIF5A and the D-arm of the P-site 
peptidyl-tRNA or with the codon displayed in the E site. However, the role of eIF5As is 
most likely to stabilize the CCA-end and mediate a peptide bond formation by inducing a 
favorable conformation of the nascent chain of the P-site peptidyl-tRNA (Gutierrez et al., 
2013; Melnikov et al., 2016; Schmidt et al., 2016b). In contrast to EF-P, eIF5a may have a 
more general role in elongation (Gregio et al., 2009; Henderson and Hershey, 2011; Saini 
et al., 2009; Schuller et al., 2017). Depleting eIF5A in the cell caused an increased number 
of polysomes and increased ribosome transit times (Saini et al., 2009). Surprisingly, such 
an effect was not found in EF-P-depleted cells (Woolstenhulme et al., 2015). Recently, the 
impact of eIF5A on termination was described. Termination by eRF1 was 16-fold enhances 
in the presence of eIF5A, while such an effect was not described for EF-P (Schuller et al., 
2017). The broad set of functions assigned to eIF5A would require a high intra-cellular 
concentration and probably a high affinity for the ribosome. In fact, eIF5A was reported to 
have roughly 273.000 copies per cell and hence, is equivalent abundant as the ribosomes. 
Therefore, eIF5A is considered to be one of the most abundant proteins in yeast (Kulak et 
al., 2014; von der Haar, 2008). In E. coli 5,000 and 50,000 copies of the ribosome per cell, 
depending on the growth rate, were reported (reviewed in:(Bremer and Dennis, 2008)). 
For the eIF5A analog EF-P 0.1 copies per ribosome were found (An et al., 1980), a later 
study suggests 20,000 copies per cell (Schmidt et al., 2016a). Hence, EF-P does not match 
the eiF5A-ribosome 1:1 ratio. For eIF5A an approximate dissociation constant of 9 nM was 
determined (Rossi et al., 2016). For EF-P, however, binding determinants and the 




1.3.7 Post-translation modifications of e/aIF5A 
eIF5A is post-translationally modified by the non-proteinogenic amino acid hypsuine 
(Nε-(4-amino‐2‐hydroxybutyl)lysine) and is so far the only reported protein carrying this 
modification (Figure 10) (Cooper et al., 1983; Folk et al., 1980; Park et al., 1981, 1982). 
eIF5A is modified immediately after emerging from the ribosome (Murphey and Gerner, 
1987; Park, 1987). The modification is mediated by two specific enzymes, deoxyhypusine 
synthase (DHS) and deoxyhypusine hydroxylase (DOHH). DHS uses spermidine as 
substrate and transfers the 4-aminobutyl moiety onto the conserved residue K51 of yeast 
eIF5A or K50 in human eIF5A (Cano et al., 2008; Park et al., 2010; Tong et al., 2009a; Wolff 
et al., 1990). The formation of deoxyhypusine via DHS relies on the coenzyme NAD+. The 
reaction proceeds through four steps, involving two imine intermediates as well as a 
hydride transition state (Wolff et al., 1997; Wolff et al., 1990; Wolff et al., 2000). DHS 
functions as a dimer, however, it tends to form a homotetramer to compensate for 
charges (Lee and Park, 2000; Wolff et al., 2000). DHS recognizes residues F30 to D80 of 
eIF5A as recognition site for K51. Mutation of the target lysine or any amino acid 
exchange within the conserved P-loop of domain I abolishes the post-translational 
modification (Cano et al., 2008; Joe and Park, 1994; Park et al., 1998; Sasaki et al., 1996). 
The deoxyhypusine hydroxylase also uses the recognition site spanning residues F30 to 
D80, which is required for both, binding to and catalytic activation of the deoxyhypusine 
hydroxylase. As a substrate, DOHH preferentially recognizes the deoxyhypusinated lysine 
form, but also recognizes the unmodified lysine (Kang et al., 2007; Park et al., 2006; 
Thompson et al., 2003). In contrast to DHS, DOHH is only essential in higher eukaryotes 
(Patel et al., 2009; Sasaki et al., 1996; Sievert et al., 2014). The DOHH of the 
corresponding gene, LIA1, in fission and budding yeast caused only light growth defects 
(Sievert et al., 2014; Weir and Yaffe, 2004). In line with these findings, both recombinant 
deoxyhypusinated and hypusinated eIF5As were able to facilitate the fM-Pmn reaction to 
a similar extend (Park et al., 2011). In higher eukaryotes, the knock-out of DOHH caused 
not only the expected lack of the hypusine modification, but also abolished the preceding 
deoxyhypusination (Sievert et al., 2014). An in vitro eIF5A modification assay revealed 
that the deoxyhypusine modification indeed was reversible (Park et al., 2003). It was 
proposed that the transformation of deoxyhypusine to hypusine masks the 
deoxyhypusine modification and removes it from the substrate-product pool of DHS and 
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thereby prevents the backward reaction to an unmodified eIF5A. eIF5A can be 
additionally modified by acetylation and phosphorylation at different modification sites 
(Ishfaq et al., 2012; Kang et al., 1993; Klier et al., 1993). The acetylation and deacetylation 
of eIF5A was linked to its intracellular location (Ishfaq et al., 2012). The role of the 
phosphorylation of eIF5A S102 remains unknown (Kang et al., 1993; Klier et al., 1993). 
 
Figure 10: Post-translational modification of eIF5A. 
A) Archaeal and eukaryotic IF5A modified to hypusine at K50 by sequential action of DHS and 
DOHH. 
 
The archaeal eIF5A homolog, aIF5A, can be either hypusinated, deoxyhypusinated or 
in very few cases both modification were found (Bartig et al., 1990). In archaea the 
mechanism of post-translation modification is not yet fully understood. For DHS a 
homolog could be identified, which appeared to mainly rely on spermidine as substrate 
and NAD+ as co-factor (Bartig et al., 1992; Bassani et al., 2018). For DOHH no homolog has 
been identified yet (Park, 2006; Wolff et al., 2007). In some higher eukaryote, a DHS was 
described to be bifunctional, performing the classic DHS-reaction as well as the DOHH 
catalyzed dehydration reaction (Quintas-Granados et al., 2016). For the studied archaea, 
however, such bifunctionality of DHS was not observed (Bassani et al., 2018). However, 
archaeal DHS can have a broader substrate pool. For a desoxyhypusine modified aIF5A, it 
was reported that the DHS used agmatine as substrate, which in a second reaction 
became transformed into deoxyhypusine (Prunetti et al., 2016). The usage of an 
alternative substrate is likely to result from the varying intracellular polyamine 
Introduction 
29 
composition in archaeal sub-species, as out of 117 halophilic archaeal strains only 20 
contained traces of spermidine (Hamana et al., 2009). Because agmatine serves as the 
precursor for an essential modification of tRNAIle it is omnipresent in archaea (Blaby et al., 
2010; Ikeuchi et al., 2010; Mandal et al., 2010). 
 
 Scope of the thesis 1.4
Elongation factor P is required to alleviate poly(Pro)-stalled ribosome complexes, ensuring 
the continuation of translation. Although the catalytic mechanism is well described, it is 
not known whether EF-P binding is limited to poly(Pro)-stalled complexes or occurs at 
every complex with a vacant E site. We developed a FRET based assay using fluorescent 
ribosome complexes and a quencher labeled EF-P, to study the binding of EF-P to 
different ribosome complexes. Biochemical and structural data suggested the D-loop of 
the tRNA bound in the P site, the post-translational modification of EF-P and the 
ribosomal protein L1 as potential key interaction partners of EF-P. In order to dissect their 
potential contribution to either binding or catalysis, we constructed different functional 
EF-P variants and used ribosomes lacking L1 in the developed binding and activity assays. 
Overall, this study contributes to the understanding of EF-P binding to the ribosome and 






 EF-P binding assay 2.1
In order to study the binding of EF-P to the ribosome, a Förster resonance energy transfer 
(FRET)-based assay was developed. FRET describes the energy transfer between two 
nearby chromophores, in which the initially excited “donor” chromophore non-radiatively 
transfers energy via dipole-dipole coupling to a second “acceptor” chromophore. 
Following energy transfer, the excited electrons of the acceptor dye relax and, depending 
on the nature of the acceptor, this relaxation can result in the emission of a photon at a 
longer wavelength than the light used to excite the donor, and also the quenching of the 
donor fluorescence. Due to the nature of the dipole coupling, the FRET efficiency depends 
on the distance between the two dyes (r) according to 1 / r6 (described in: (Harris, 2010; 
Helms, 2008; Valeur, 2012)). This strong distance-dependence makes FRET highly suitable 
for the study of binding and conformational changes between two fluorescently-labeled 
reactants. The distance at which the FRET efficiency reaches 50% is called Förster distance 
(R0). Depending on the distance between the FRET partners, the assay will be either be 
more sensitive (for R close to R0) or less sensitive to small changes in the dye spacing. For 
the EF-P binding assay developed in this work, a FRET-efficiency of about 95% can be 
assumed for the bound state, and thus the assay will report robustly on binding while 
being insensitive to other events such as conformational rearrangement. The combination 
of FRET with a rapid kinetic method, such as stopped flow, then allows real time 
monitoring of binding. 
To study EF-P binding to the ribosome, EF-P was labeled with a fluorescence acceptor 
and the ribosome with a fluorescence donor (Figure 12A). The mRNA, tRNAs, ribosomal 
protein L1 and L33 were considered as potential labeling sides for the fluorescent donor. 
Structural studies suggested that ribosomal protein L33 might be the most suitable 
labeling site to form a FRET pair with bound EF-P (Blaha et al., 2009). L33 is located 
between the E and P site on the 50S subunit, and in contrast to the other considered 
labeling sides, it does not change the position during translation. Upon binding of EF-P to 
the E site, EF-P and L33 come into close proximity, which is a prerequisite for FRET. 
Preparation of ribosome complexes containing an Alexa Fluor™ 488-labeled L33 has been 
were already established, and their biochemical and photophysical properties validated 
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by Belardinelli et al. (Belardinelli and Rodnina, 2017; Belardinelli et al., 2016a; Belardinelli 
et al., 2016b; Goyal et al., 2015; Sharma et al., 2016). As fluorescent acceptor attached to 
EF-P, the non-fluorescent quencher QSY35 was used. In contrast to a classic FRET pair, the 
increasing concentration of the fluorescent acceptor does not affect the fluorescence 
signal and hence requires no correction, e.g. during titrations. 
 
2.1.1 Labeling of EF-P 
In order to monitor EF-P binding, EF-P was labeled with a fluorescence acceptor. 
Sulfhydryl-reactive fluorescent dyes allow the site-specific labeling at cysteine residues. 
Wild type EF-P contains one cysteine, which, however, is not solvent accessible and did 
not react with dye. For the site-specific labeling of EF-P, single amino acid residues were 
exchanged to cysteine. Candidate amino acids were selected considering potential steric 
clashes with the ribosome, degree of conservation of the exchanged amino acid residue, 
distance to the FRET partner and potential solvent accessibility based on the X-ray 
structure of EF-P-bound to the ribosome [PDB 4V6A] (Blaha et al., 2009). Ten potential 
mutation sites were identified (Figure 12 and Table 1). Each EF-P variant was 
overexpressed together with the EF-P modifying enzymes in E. coli BL21 (DE3). EF-P was 







Figure 11: Structure and labeling sites of L33 and EF-P. 
Indicated are the introduced cysteine residues for site-specific labeling of EF-P (magenta) and 
the labeling position in L33 (green). Distances are shown as yellow dashed lines for each 
potential FRET pair. Based on X-ray structure [PDB4V6A (Blaha et al., 2009)]. 
Table 1: EF-P labeling site and distance (r) to L33 P31C 
To achieve a high labeling efficiency and prevent dimerization by disulfide-bridges, 
EF-P cysteine residues were reduced prior to labeling. The pH was adjusted such that the 
sulfhydryl groups remained deprotonated, while the thio-reactive linker of the dye 
remained active. Four different fluorescent acceptors (ATTO540Q, QSY-7, QSY-9 and 
QSY-35) with either iodacetamide or maleimide as reactive group were tested. With three 
of the tested dyes, independent of the linker, only low labeling efficiencies were achieved 
or the labeled protein precipitated. Maleimide would have been the linker of choice, 
because it is more stable and has a higher specificity. Added in large excess, 
iodoacetamide was reported to be able to alkylate amines (lysine), carboxylates 
(aspartate, glutamate), imidazols (histidine) and thioester (methionine) and therefore is 
less specific (Jullien and Garel, 1981; Michaelis, 1934; Yang and Attygalle, 2007). The only 
dye which yielded a high labeling efficiency of 80% and a soluble protein was QSY35, 
which was only available as iodoacetamide. 
The QSY35-labeled EF-P variants were applied to a stopped-flow apparatus to test 
their ability to quench the fluorescent of ICs containing 50S subunits which were 
reconstituted with L33 labeled with AlexaFluor™ 488 (L33Alx). For most tested variants 
only a small change in donor fluorescence (10 - 15%) was observed, with the exception of 
Results 
33 
EF-P D66C (QSY35) (EF-P(QSY)), which caused a 30% fluorescence decrease upon binding 
to the ribosome. This EF-P derivative was used in the following study. 
 
Figure 12: EF-P binding assay. 
A) Schematic of the EF-P binding assay based on FRET between EF-P(QSY35) (turquoise, the 
position of fluorescence reporter is indicated orange and ribosomes (IC(L33Alx)) containing 
L33 labeled with AlexaFluor™ 488 (L33Alx) (green). The P-site tRNA is shown in blue. 
 
2.1.2 Validation of the EF-P binding assay 
We next validated that the observed fluoresc3nce donor change reflects reversible 
binding of EF-P to the ribosome. The amplitude of the fluorescence change of 
70S IC(L33Alx) was roughly 30% in the presence of EF-P(QSY). In the absence of EF-P(QSY), 
the signal of the donor remained stable over time (Figure 13A). The eukaryotic EF-P 
homolog, eIF5A, was reported to interact with the 60S subunit (Rossi et al., 2016), which 
prompted us to test whether EF-P(QSY) binds to 50S(L33Alx) subunit. However, no signal 
change was observed, suggesting that EF-P does not bind to the 50S subunits. A small 
(10%) fluorescence change was observed with vacant 70S ribosomes containing L33Alx, 
suggesting that EF-P interacts weaker with vacant ribosomes than with ICs (10% vs 30% 
change in amplitude). 
To further validate the assay and to obtain insights into the binding kinetics, we 
recorded time courses of EF-P(QSY) binding to 70 IC(L33Alx) (Figure 13B). A concentration 
dependent fluorescence decrease was observed, supporting the notion that the observed 
event indeed depends on EF-P binding to the ribosome. The apparent rate constants of 
EF-P binding to ICs were determined by two-exponential fitting with an additional slope. 
The apparent rate constants (Figure 13C) and the respective amplitudes (Figure 13D) 
were used to calculate the association (kon) and dissociation (koff) rate constants and the 
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equilibrium dissociation constant (Kd). The Kd is defined as the quotient of the dissociation 
and association rate constants. The apparent rate constant of the fast step (kapp1) depends 
linearly on the concentration, indicating that it reports on the binding step. The kon value 
can be derived from the slope of the linear fit of the concentration dependence. The 
intercept of the fit with the y-axis yields the koff. The association rate constant was 
kon = 56 µM
-1 s-1 and dissociation rate koff = 58 s
-1. The binding rate constant (Kd) was 
about 1 µM based on the kon and koff values. In addition, the Kd value can be obtained 
from the concentration dependence of the amplitude of the signal change (reviewed in: 
(Bernasconi, 1976; Klostermeier, 2017)), which was about 1 µM (Fig. 12D). The slower 
phase of the binding time course had a very small amplitude (Fig. 12D) and no 
concentration dependence (Fig. 12C) and was not considered further. 
In order to investigate whether the labeling affected EF-P function, its ability to 
facilitate peptide bond formation was tested. Fluorescence-labeled fMP 
post-translocation complexes (Post(fMP)(L33Alx) were mixed with puromycin (Pmn) 
acting as A-site substrate analog in the presence or absence of EF-P and EF-P(QSY). The 
amino moiety of the aminonucleoside antibiotic puromycin reacts with peptidyl-tRNA, 
resulting in a peptide-puromycin product. The reaction of Post(fMP)s with Pmn is 
accelerated by EF-P up to 90-fold (Doerfel et al., 2013), providing a large dynamic window 
to detect changes. The reaction of Post(fMP)(L33Alx) with Pmn was performed in a 
quench-flow apparatus which is suitable to measure rapid kinetics in a millisecond to 
second range. The products were purified from unreacted substrates via reversed-phase 
chromatography and the yield plotted as function of the reaction time. The time courses 
were similar with EF-P and EF-P(QSY). The time courses were analyzed by one-exponential 
fitting (Figure 13E), allowing to derive an observed reaction rate. The reaction rate was 
0.2 ± 0.1 s-1in the absence of EF-P, 4.2 ± 0.8 s-1 in the presence of native EF-P, and 
9.4 ± 0.8 s-1with EF-P(QSY). Thus, fluorescence labeling did not impair the functional 




Figure 13: Validation of the EF-P binding assay. 
A) Interaction of EF-P with potential binding partners, monitored by FRET using a stopped-flow 
apparatus. Fluorescent L33Alx-labeled 50S subunits (red), vacant 70S ribosomes (orange) and 
70S IC (green) were rapidly mixed with EF-P(QSY). Buffer was used in the donor-only trace 
(grey). 
B) Binding of EF-P(QSY) to unpurified 70S IC(L33Alx). The binding was monitored in a stopped-
flow apparatus and ICs were titrated with EF-P(QSY) at the following concentrations: 0.25 µM 
(ochre), 0.5 µM (green), 1 µM (turquoise), 3 µM (purple) and 4 µM (magenta). The fits are 
shown as light color of corresponding trace. Buffer was used for the donor-only trace (grey). 
C) Concentration dependence of the apparent rate constants (kapp1, black and kapp2, red) 
derived from a two-exponential fit of the traces in B and the linear fit of kapp1. 
D) Concentration dependence of amplitudes (black, Aapp1 and red, Aapp2) derived from a 
two-exponential fit of the traces in B. Black line shows a hyperbolic fit of A1 value. 
E) Activity of fluorescence-labeled components. Formation of fMP-Pmn was measured using 
Post(fMP)(L33Alx) complex (0.2 µM) and Pmn (10 mM) in the absence (grey) or presence of 
EF-P(QSY) (3 µM; red) and unlabeled EF-P (3 µM; black). The experiments was carried out using 
a quench-flow apparatus, were reactants were rapidly mixed, incubated for the indicated 
times, then quenched and the products analysed by HPLC. 
F) Time resolved in vitro translation of fMPPPF monitored by FRET. 70S IC(L33Alx) was rapidly 
Results 
36 
mixed in a stopped-flow apparatus with EF-P(QSY) (0.5 µM), EF-G (1 µM), Pro-TC (2 µM) and 
Phe-TC (2 µM). Red: in the presence of all components, blue: lacking Phe-TC; and mint: lacking 
EF-G. Buffer was used for the donor-only trace (grey). 
 
In order to study the binding of EF-P to the ribosome during translation, EF-P(QSY35) 
was added to a fully reconstituted translation assay. Here, IC(L33Alx) programmed with 
an mRNA encoding fMPPPF were used as a model complex, as translation of the PPP 
motif requires EF-P (Doerfel, 2016; Ude et al., 2013). However, the observed time courses 
were too complex to analyze by exponential fitting (Figure 13F). In the absence of EF-G, a 
small initial decrease in fluorescence was followed by a very slow, biphasic fluorescence 
decrease. The origin of these fluorescence changes is not clear. In the absence of EF-G, 
binding of the first TC-Pro should occur, resulting in the formation of the hybrid state of 
the ribosome, but the subsequent translocation cannot take place. EF-P seems not to bind 
to the hybrid-rotated ribosomes, as the initial amplitude change is small, but with time 
EF-P binding to the fraction of the non-rotated ribosomes may shift the equilibrium 
towards ribosome-EF-P complexes, resulting in a further fluorescence change; some 
extent of spontaneous translocation cannot be excluded as well. The time course 
obtained in the absence of Phe-TC, showed a small fluorescence decrease similar to the 
initial decrease recorded in the absence of EF-G, followed by another small decrease, a 
plateau and a final large decrease in fluorescence. In a simplest model, this patter would 
reflect the binding of the TC-Pro, translocation, and binding of the 2nd TC-Pro, which 
reflect rounds of EF-P binding and dissociation from different transient translation steps. 
After the incorporation of the 2nd Pro, stable binding of the 3rd TC-Pro is impaired (Doerfel 
et al., 2013; Peil et al., 2013; Ude et al., 2013), and this complex is the true substrate for 
EF-P binding, which explains the largest fluorescence change. Addition of TC-Phe reduces 
the final fluorescence, as a fraction of EF-P dissociates from the ribosome upon TC-Phe 
incorporation and translocation. Despite the set of different conditions, the traces were 
too complex to assign specific translation events to each signal change. Nevertheless, 
overall a robust FRET-based EF-P binding assay was developed, while its components 




 Determinants for EF-P 2.2
Previous reports suggested that the E-site mRNA codon, the P-site peptidyl-tRNA, 
post-translational modification of EF-P, and the ribosomal protein L1 may affect the 
binding of EF-P to the ribosome (Blaha et al., 2009; Doerfel et al., 2013; Huter et al., 2017; 
Katoh et al., 2016). So far, all conclusions regarding the binding of EF-P have either been 
indirectly derived from the ability of EF-P to catalysis peptide bond formation or 
concluded from structural insights. By applying the established EF-P binding assay, the 
impact of the described binding determinants was tested. 
 
2.2.1 E-site context 
A cryo-electron microscopic study suggested a potential interaction between EF-P and the 
E-site codon (Huter et al., 2017). It was proposed that in the ribosome–EF-P complex the 
bases of the E-site codon are hydrogen bonding distance with the conserved residues 
D145, T146 and G148 in loop I of EF-P domain III. This finding was further supported by 
molecular dynamics simulations which predicted that the nature of the bases of the E-site 
codon can influence binding. Biochemical experiments showed mutations in loop I of EF-P 
domain III reduced or abolished the ability of EF-P to rescue poly(Pro)-stalled ribosomes 
(Huter et al., 2017). In order to address a potential interaction the loop I with the mRNA 
E-site codon, the corresponding amino acids in EF-P were mutated in the EF-P D66C 
labeling variant. The conserved aspartic acid residue (D145) was exchanged to valine, and 
the conserved threonine (T146) to alanine and valine. In addition, EF-P truncation 
(ΔL142-G144, D145G, T146G, ΔA147-T149) variant was constructed. Residue G148 was 
not changed, because it is supposed to interact with the mRNA via its amino acid 
backbone. The exchange of glycine with proline would have changed the putative 
backbone interaction, however, it would also have a major influence on the conformation 
of the loop. EF-P variants were overexpressed in E. coli BL21 (DE3), purified according to 
standard procedure and labeled with QSY35. 
The labeled EF-P variants were used for the EF-P binding assay (Figure 14A). The 
fluorescence signal was small with any of the EF-P loop I mutants than with EF-P(QSY). 
Both T146 variants showed an amplitude of less than 5% and EF-P D145V of 20%, 
compared to 30% amplitude change upon binding of EF-P(QSY). The reduced fluorescence 
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decrease could indicate a lower affinity of EF-P or correspond to a lower FRET efficiency, 
resulting from a different orientation of the bound EF-P. 
 
Figure 14: Binding of EF-P flexible-loop variants. 
A) Binding of EF-P(QSY) domain III variants to 70S IC(L33Alx). EF-P was rapidly mixed with 70S 
IC(L33Alx) in a stopped-flow apparatus und FRET was monitored. Traces in the presence of 
EF-P(QSY) are shown in black, T146A(QSY) in blue, T146V(QSY) in green, and D145V(QSY) in 
purple. Buffer was used for the donor-only trace (grey). 
B) Titration of EF-P(QSY) domain III variants to 70S IC(L33Alx) in a fluorimeter. The fluorescence 
change with increasing concentration of EF-P(QSY) variants in equilibrium was plotted. The 
color code is as in A. The dissociation constant Kd for each EF-P variant was calculated using a 
quadratic equation. 
 
In order to determine the Kd value for the EF-P variants, an equilibrium titration was 
performed (Figure 14B) in a spectrofluorimeter monitoring the change of the 
fluorescence upon addition of increasing concentrations of EF-P. The observed amplitudes 
are very similar to the one observed in the corresponding stopped-flow experiment. To 
analyze the titration curve, we used a quadratic equation, which takes into account the 
difference between added and free concentration of the titrated component (EF-P in our 
case) depending on the concentration of the ligand present in constant concentration 
(the ribosome complex). The Kd value was 0.2 µM for EF-P(QSY) and 0.1 - 0.3 µM for the 
EF-P domain III loop I variants (D145V: 0.1 µM, T146A: 0.1 µM and T146V: 0.3 µM). Thus, 
against the expectation, the loop I mutants did not impair the binding affinity of EF-P. This 
finding indicates that the E-site codon does not affect EF-P binding and speaks against the 
sampling of the displayed codon by loop I of EF-P domain III. However, the applied 
method did not allow to determine the binding and dissociation rate. For that a rapid 
kinetic technique, such as stopped-flow, would be required. 
Because the EF-P loop variants did not show an increased dissociation constant, we 
asked the question whether the native loop is able to distinguish different bases. 
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Molecular dynamics simulations suggested that the nature of the -2 and -3 base can 
hinder, weaken or allow binding of EF-P (Huter et al., 2017). To study the interaction of 
EF-P (with its native loop I) with the E-site, complexes were needed which vary only in the 
codon displayed E site. To change the E-site codon, while keeping the same peptidyl-tRNA 
in the P site, we designed mRNA constructs that share the same sequence, except for the 
codon downstream of the AUG initiation codon (Figure 15). Initiation complexes were 
formed using these mRNAs, with either an Ile (IleIC) or Pro (ProIC) codon in the E site. 
Thus, the interaction of EF-P with the E-site codon could be study, while other 
determinants of EF-P binding, in particular the tRNA in the P site, remained the same. 
 
Figure 15: mRNA constructs used to study the EF-P E-site mRNA codon interaction. 
mRNAs have the same sequence except for the codon down preceding the AUG. The isoleucine 
codon (AUA) was suggested to be unfavorable for EF-P binding, whereas, the proline codon 
(CCG) represents a suggested favorable binding interface (Huter et al., 2017). The Shine-
Dalgarno sequence is indicated in italics. 
 
Fluorescence-labeled initiation complexes with either of these mRNAs were formed 
and used in the EF-P binding assay. The change in fluorescence was dependent on EF-P 
concentration (Figure 16A and B). The apparent rate of EF-P binding was determined by 
two-exponential fitting with an additional slope. The binding rate kon and the dissociation 
rate were determined from the linear fit of the kapp1 concentration dependence (Figure 





Figure 16: Influence of the E-site codon on EF-P binding. 
A) Binding of EF-P(QSY) to initiation complexes displaying the Ile codon AUA in the E site. The 
binding was monitored in a stopped-flow apparatus. Ile IC(L33Alx) mixed with increasing 
EF-P(QSY)concentrations: 0.25 µM (ochre), 0.5 µM (green), 1 µM (turquoise), 1.5 µM (blue) and 
3 µM (purple). The fits are shown as light color of corresponding trace. Buffer was used for the 
donor-only trace (grey). 
B) Same as A, but with the Pro codon CCG in the E site. 
C) Concentration dependence and linear fit of the apparent rate constant (kapp1) derived from a 
two-exponential fit of the traces in A. 
D) Same as in C with an outlier in grey, for traces of B. 
 







] Kd [µM] Kd* [µM] 
IleIC(L33Alx) 39 ± 2 10 ± 2 0.3 ± 0.1 0.25 ± 0.02 
ProIC(L33Alx) 44 ± 7 44 ± 12 1 ± 1 0.14 ± 0.02 
Kd* is derived from titration in a fluorimeter. Whereas, kon and koff are derived from 
stopped-flow experiments. The Kd is the quotient of koff and kon. 
 
Surprisingly, EF-P binding rate constants were similar on the two codons (Table 2). 
The dissociation rate for EF-P and complexes with a proline codon in the E site is 
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erroneous due to an outlier. However, the in equilibrium titration showed the association 
rate constants to be independent of the displayed E-site codon. 
To further validate the conclusion that the E-site codon has little effect on EF-P 
binding, we performed equilibrium titrations of initiation complexes displaying the CCG 
codon in the E-site (ProIC(L33Alx)) with the EF-P variants with mutations in domain III loop 
I. Binding of EF-P(QSY) and D145V(QSY) had a maximum amplitude of about 30% and the 
titrations were nearly identical. The amplitude for T146A(QSY) and T146V(QSY) is only 5%, 
and these two titration curves also coincide. The observed amplitudes are similar to those 
of EF-P binding to IleIC(L33Alx) (Figure 16). For all tested variants including EF-P (wt) a Kd 
of 0.15 µM was calculated (Figure 17B). Thus, the affinity of EF-P to the initiation complex 
is independent of the E-site codon or the loop I in EF-P domain III. Overall, this work 
suggests that integrity of the flexible loop I is of relevance for the activity of EF-P, the 
nature of the E-site codon, however, is of little relevance for EF-P binding and activity. 
 
Figure 17: Binding and affinity of EF-P flexible loop variants to different E-site codons. 
A) Titration of EF-P(QSY) domain III variants to IC(L33Alx) in a fluorimeter. Data points 
corresponding to EF-P(QSY) are shown in black, T146A(QSY) in blue, T146V(QSY) in green and 
D145V(QSY) in purple. Buffer was used for the donor-only trace (grey). The dissociation constant 
Kd for each EF-P variant was calculated using a quadratic equation. 
B) Equlibrium dissociation constants (Kd) of EF-P(QSY) and its domain III variants for IC(L33Alx) 
displaying either the Pro codon CCG (black) or the Ile codon AUA (white) in the E site. The Kds 
values are from A. 
 
2.2.2 Peptidyl-tRNA context 
Structural studies showed an interaction between EF-P and the D-arm of the P-site bound 
peptidyl-tRNA (Blaha et al., 2009; Huter et al., 2017). The relevance of the D-arm for EF-Ps 
function was demonstrated by biochemical studies (Katoh et al., 2016). The D-arm 
architecture of tRNAPro, which is shared by tRNAfMet but not other tRNAs, was shown to be 
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a perquisite for the ability of EF-P to facilitate peptide bond formation. This effect was 
proposed to result from a higher affinity of EF-P for the D-arm of tRNAPro and tRNAfMet 
compared to other tRNAs (Katoh et al., 2017a). 
In chapter 2.1 I have shown that EF-P binds to the initiation complexes displaying 
fMet-tRNAfMet as a P-site tRNA. In order to address the question whether and to which 
extend the P-site peptidyl-tRNA influences the binding of EF-P, different fluorescent 
post-translocation complexes were prepared and EF-P binding was measured (Figure 
18A). The complexes Post(fMF)(L33Alx), Post(fMP)(L33Alx) and Post(fMPP)(L33Alx) were 
formed and titrated with EF-P(QSY). Fluorescence changes and amplitudes were similar 
for the three complexes (Figure 18A, B and C). The binding rate constant kon and the 
dissociation rate constant koff were determined from the linear fit of the kapp1 
concentration dependence (Figure 18D, E and F). The binding and dissociation constants 





Figure 18: Influence of the P-site tRNA on EF-P binding. 
A) Schematic of the EF-P binding assay to study the interaction of EF-P with peptidyl-tRNA. 
B) Binding of EF-P(QSY) to fMF-post-translocations complexes (Post(fMF)(L33Alx)) monitored in 
a stopped-flow apparatus. Post(fMF (L33Alx) was mixed with different EF-P(QSY) 
concentrations: 0.25 µM (ochre), 0.5 µM (green), 1 µM (turquoise), 1.5 µM (blue) and 2 µM 
(magenta). Buffer was used for the donor-only trace (grey). 
C) As B, but with Post(fMP)(L33Alx) complexes which contain tRNA
Pro
. 
D) As B, but with Post(fMPP)(L33Alx) complexes with tRNA
Pro
 in the P site and a Pro codon 
displayed in the E site. 
E) Concentration dependence and linear fit of the apparent rate constant (kapp1) derived from a 
two-exponential fit of the traces in B. 
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F) Same as in E, for traces of C. 
G) Same as in E, for traces of D. 
 







] Kd [µM] 
fMF 79 ± 5 90 ± 6 1.1 ± 0.1 
fMP 71 ± 4 25 ± 4 0.4 ± 0.1 
fMPP 50 ± 3 1 ± 3 0.02 ± 0.06 
 
The rates of EF-P binding to Post(fMF)(L33Alx) and Post(fMP)(L33Alx) were found to 
be the same, whereas for Post(fMPP)(L33Alx) the binding rate was 1.5-fold slower. 
Comparing complexes with a functional context (proline containing) with non-proline 
containing complexes, EF-P dissociated from Post(fMF)(L33Alx) 3- to 90-fold faster, with 
an affinity reduced by 3- to 50-fold (Table 3). Comparing the two proline containing 
complexes, showed that the addition of one proline to the nascent chain, resulted in a 
slight reduction of the on rate and but in a 25-fold reduction of the off rate. Hence, the di-
prolyl moiety itself or a resulting alternative positioning of the peptidyl-tRNA has to 
explain the differences in binding. Overall, these findings are in agreement with the 
biological relevance of EF-P. Complexes, potentially requiring EF-P assistance during 
translation were bound with a higher affinity. The lower Kd results from a reduced koff, 
while kon remained roughly the same. This finding suggesting a sampling mechanism of 
EF-P based on a koff effect. Overall, the findings indicate that the P-site peptidyl-tRNA has 
an impact on the EF-P binding kinetic, however, the functional context of a 
poly(Pro)-stalled complex must provide additional interaction surfaces, resulting in a 
reduced dissociation and hence, higher affinity. 
 
2.2.3 EF-P modification 
Unmodified EF-P is impaired in its ability to facilitate peptide-bond formation between 
consecutive Pro residues and was proposed to have a lower affinity towards the ribosome 
(Doerfel et al., 2013; Ude et al., 2013). In order to investigate the impact of the 
modification on binding, the genes of the modifying enzymes EpmA, B and C were deleted 
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from the overexpression plasmid encoding the EF-P labeling variant. Overexpression of 
EF-P leads to a dramatic increase of its cellular concentration. Previous studies have 
shown by mass-spectrometry that natively expressed EF-P modification enzymes are not 
sufficient to sufficiently modify the overexpressed EF-P and the majority of EF-P remained 
unmodified (Doerfel et al., 2013). The binding of unmodified EF-P(QSY) was tested in the 
EF-P binding assay using the following post-translocation complexes: Post(fMF)(L33Alx), 
Post(fMP)(L33Alx) and Post(fMPP)(L33Alx). For all three complexes a concentration-
dependent decrease of the fluorescent signal was observed (Figure 19A, B and C). The kon 
and koff were determined from the linear fit of the apparent rate constant kapp1
 
concentration dependence (Figure 19D, E and F) and used to calculate the equilibrium 






Figure 19: Effect of the (β)-hydroxy-lysinylation on EF-P binding. 
A) Binding of unmodified EF-P(QSY) to fMF-post-translocations complexes (Post(fMF)(L33Alx)). 
The binding was monitored in a stopped-flow apparatus. Post(fMF (L33Alx) were titrated with 
EF-P(QSY): 0.25 µM (ochre), 0.5 µM (green), 1 µM (turquoise), 1.5 µM (blue) and 3 µM (purple). 
Buffer was used for the donor-only trace (grey). 
B) As A, but with Post(fMP)(L33Alx) complexes. 
C) As A, but with Post(fMPP)(L33Alx) complexes and additionally 2 µM EF-P(QSY) (magenta). 
D) Concentration dependence and linear fit of the apparent rate constants (kapp1) derived from a 
two-exponential fit of the traces in A. 
E) Same as in D, for traces of B. 
















] KD [µM] 
fMF 44 ± 2 29 ± 3 0.7 ± 0.1 
fMP 42 ± 1 10 ± 1 0.2 ± 0.1 
fMPP 37 ± 2 3 ± 2 0.08 ± 0.07 
 
The association rate constants of unmodified EF-P were similar for the tested 
post-translocation complexes, in-line with the results obtained with fully-modified EF-P. 
The dissociation rate constants of unmodified EF-P showed the same tendencies as with 
modified EF-P. The dissociation of unmodified EF-P from fMF-complexes was 3- to 10-fold 
faster than from proline-containing complexes. A comparison of the two proline 
containing complexes showed that the addition of one proline to the nascent chain 
results in a 3-fold reduction of the off rate. Interestingly, modified EF-P showed a 25-fold 
difference between POST(fMP) and POST(fMPP) complexes. Overall, unmodified EF-P 
binds all complexes with the same rate, whereas the dissociation varies depending on the 
complex. This suggests that despite its catalytic relevance the modification of EF-P also 
contributes to binding. However, the observed difference in binding between modified 
and non-modified EF-P are too little to account fully for the reduced activity of 
unmodified EF-P. 
 
2.2.4 Ribosomal protein L1  
EF-P bound to the ribosomes was reported to interact with the ribosomal protein L1 
which was proposed to be involved in EF-P binding and dissociation (Blaha et al., 2009; 
Huter et al., 2017). The EF-P binding assay employing FRET between EF-P and the 
ribosomal protein L33 was not suitable to study the role of the ribosomal protein L1 for 
EF-P binding, because this would have required a 50S subunit variant lacking both L1 and 
L33 (Cornish et al., 2009). To create such a double deletion variant is not feasible. To 
overcome this bottleneck, EF-P D66C was labeled with Alexa Fluor™ 488 (EF-P(Alx)), which 
Results 
48 
allowing to use a change in the anisotropy upon binding of EF-P to ΔL1 50S subunits 
(Trabuco et al., 2010). Increasing concentrations of initiation complexes lacking L1 
(IC(ΔL1)) added to EF-P(Alx) and the change in fluorescence anisotropy of the EF-P(Alx) 
was monitored (Figure 20A). 
 
Figure 20: EF-P binding in the absence of L1. 
A) Schematic of EF-P(Alx) binding to IC(ΔL1). The binding was studied by monitoring the 
anisotropy change of EF-P(Alx). 
B) Change of EF-P(Alx) anisotropy with increasing concentration of 70S IC, fitted with the 
quadratic equation; closed symbols, 70S IC(wt); open symbols, IC(ΔL1). 
 
The sample was exposed to linearly polarized light, in which the electric field vector 
oscillates in a single defined plane. Randomly polarized light can be converted into 
linearly polarized light using a polarizer. However, it was found that excited fluorophores 
emit partially polarized light and that the degree of polarization increased with the size of 
the dye and viscosity of the solvent, while an increase in the temperature decreased the 
degree of polarization. This means that at a defined temperature the fluorescence 
anisotropy correlates with the mobility of the dye. Thus, a less mobile emitting species 
will emit light which is more polarized. Hence, freely rotating fluorophores in solution 
have exhibit a low anisotropy, whereas fluorophores associated with large molecules 
have a higher anisotropy. The anisotropy values were plotted as a function of the IC 
concentration. For both complexes the same anisotropy change with increasing ribosome 
complexes was observed (Figure 20B). The Kd values derived by fitting to a quadratic 
equation were 1.0 ± 0.2 µM for native IC and 1.3 ± 0.4 µM for ΔL1 IC. Thus, L1 does not 
influence the affinity of EF-P to the ribosome. However, no information on the binding 
and dissociation rates were obtained, which would require further rapid kinetic 
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techniques and chase experiments. Overall, we could show that the affinity of EF-P to the 
ribosome is independent of the ribosomal protein L1. 
 Catalysis of peptide bond formation by EF-P 2.3
So far we found that the nature of the P-site peptidyl-tRNA had a major effect on the 
binding kinetics of EF-P (section: 2.2.2), while the other suggested binding determinants 
had no significant contribution to the binding. The affinity of EF-P to initiation complexes 
was neither effect by the displayed codon in the E site, nor by the lack of ribosomal 
protein L1 (section: 2.2.1 & 2.2.4). The post-translational modification of EF-P showed a 
minor effect on the binding of EF-P and its lack resulted in slightly reduced association 
rate and increased dissociation rate (section: 2.2.3). The observed differences in binding 
appear to be too little to account for the reported reduced catalytic activity of unmodified 
EF-P (Doerfel et al., 2013; Ude et al., 2013). Because most of the suggested EF-P key 
interaction partners did not contribute to binding, different assays were used to study 
their influence on the ability of EF-P to facilitate peptide-bond formation. 
 
2.3.1 The E-site codon 
Structural data suggest that both sidechains and the backbone of the conserved GDT 
motif in loop I of domain III of EF-P come into hydrogen-bridging distance with the E-site 
codon (Huter et al., 2017). Hence, the nature of the E-site codon and the residues of the 
conserved loop could alter the interaction of EF-P with the ribosome. 
To test this experimentally, EF-P activity was tested with different ribosome complexes in 
a quench-flow apparatus using the puromycin assay. The reaction between initiation 
complexes and the A-site substrate analog puromycin was shown to be facilitated by EF-P 
more than 5-fold (Doerfel et al., 2013), which makes the reaction suitable to test the 
reactivity of EF-P. Initiation complexes displaying either the isoleucine codon AUA or the 
proline codon CCG in the E-site were treated with the A site substrate analog puromycin 
in the presence of sub-saturating concentrations of EF-P (Figure 21A). The time courses of 
fMet-Pmn formation were independent of the E-site codon (Figure 21B). The reaction rate 
was calculated by one-exponential fitting of the time courses. In both cases, the reaction 
rate was the same (kobs= 0.43 ± 0.04 s
-1). This shows that the E-site codon does not affect 
the ability of EF-P to stimulate peptide bond formation. The relevance of loop I of 
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domain III of EF-P was addressed in collaboration with the Wilson lab, which established 
different loop I variants. In order to address the suggested interaction of GDT sidechain 
with the E-site codon, the corresponding amino acids were substituted with alanine 
(EF-P 144AAA146). The contribution of the GDT backbone to a potential E-site interaction 
was investigated by deleting 1, 2 or 4 residues of loop I (EF-P (loopIΔ1), (loopIΔ2), and 
(loopIΔ4)). The eukaryotic EF-P homolog eIF5A consists only of two domains. To mimic 
this protein, an eIF5A analog EF-P variant missing the whole domain III was created 
(EF-P (Δdomain III). These variants were tested for their ability to stimulate the synthesis 
of a fMPPPF peptide in a reconstituted in vitro translation system (Figure 21C). In the 
translation reactions supplemented with EF-P (loopIΔ1), 70% of all complexes produced 
the fMPPPF product. In the presence of EF-P (144AAA146) or EF-P (loopIΔ2), 50% and 40% of 
the complexes formed products. With EF-P (loopIΔ4) and EF-P (Δdomain III), almost no 
product formation was observed. Because the translation reaction competes with side 
reactions, such as peptidyl-tRNA drop-off, the product yield directly correlates with the 
activity of EF-P. Impaired EF-P catalyzes less product formation in a given time, while the 
drop-off reaction proceeds at constant rate, reducing the available substrates and hence 
limits the number of possible translation reactions. The maximum product yield was 
determined by supplementing the translation mix with EF-P (wt), in which 70% of the 
complexes formed the full-length product, which is in agreement with previously reported 
data (Doerfel et al., 2013). EF-P (wt) activity was only achieved by EF-P (loop I Δ1). The 
deletion of the adjacent residue in loop I, EF-P (loopIΔ2), resulted in a reduced activity. 
The deletion of the flexible loop, resulted the inactivation of EF-P (loopIΔ4). Complete 
activity loss was also observed for EF-P lacking domain III. Interestingly, the replacement 
of the GDT motif that was proposed to interact with the E-site codon with AAA 
(EF-P 144AAA146) caused only a slight reduction in activity. To further investigate the role of 
the D145 and T146, EF-P (D145L), (D145V), (T146A) and (T146V) variants were created 





Figure 21: Influence of the E-site codon on EF-P facilitated catalysis. 
A) Position of the EF-P domain III (d3) loop I, with residues G144, D145, and T146 of EF-P may 
interact with the E-site mRNA codon. Adopted from: Figure 8A. 
B) Scheme of the puromycin assay using the aminonucleoside Pmn as A-site substrate analog. 
C) Time courses of fMet-puromycin formation with ICs presenting an the Ile codon AUA (IleIC, 
black circles)) or the Pro codon CCG (ProIC, red circles) in the E-site. The reaction was performed 
in the presence of sub-saturating concentrations of EF-P. 
D) Activity of EF-P domain III loop I variants. Synthesis of the fMPPPF peptide in the presence of 
increasing concentrations of EF-P wt, black; loopIΔ1., blue; 144AAA146, red; loopIΔ2, light blue; 
loopIΔ4, urquoise; and Δdomain III, green (adopted from (Huter et al., 2017)). 
E) Time course of fMet-Pmn formation with EF-P (wt) (black squares) and EF-P mutants D145L 
(dark blue triangles) and D145V (light blue reverse triangles). 
F) Time courses of fMet-Pmn formation with EF-P (wt) (black squares) and EF-P mutants T146A 
(dark green triangles) and T146V (light green reverse triangles). 
 
With EF-P (wt), (D145L) and (T146A) similar reaction rates were obtained of 
about 0.43 ± 0.04 s-1. The substitution of D145V and T146V showed a reduced kobs of 
about 0.12 ± 0.02 s-1, which corresponds to the reported non-catalyzed reaction rate 
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(Doerfel et al., 2013), suggesting that substitution of D145 or T146 with valine abolished 
EF-P activity, whereas EF-P (D145L) and (T146A) remained as active as EF-P (wt). The 
substitution of the charged aspartic acid with a hydrophobic residue did not reduce the 
activity of EF-P. Hence, it is unlikely that the side chains of D and T as such are important 
for the function. These conclusions are supported by the EF-P (144AAA146) variant which 
showed only a slight reduction in it activity. These findings underscore that the E-site 
codon does not affect EF-P activity, but rather the integrity or the conformation of loop I 
is important. This conclusion is in agreement with the findings concluded in section 2.2.1, 
in that the binding of EF-P is independent of an E-site codon interaction. 
 
2.3.2 The post-translational modification of EF-P 
The (R)-β-lysylhydroxylysine modification of EF-P lysine 34 is crucial for the functional 
activity of EF-P (Doerfel et al., 2013; Ude et al., 2013). While the hydroxylation of K34 
showed only a minor effect on the ability of EF-P to facilitate peptide bond formation, the 
(R)-β-lysinylation had a major impact (1.3.2). Replacement of Lys34 by Ala abolishes the 
modification (chapter 1.3.7). To investigate whether the body of EF-P, independent of 
EF-P modification and lysine 34, can contribute catalysis, the biochemical activities of 
modified, unmodified EF-P and EF-P K34A were compared. In order to do so, the 
corresponding EF-P variants were used in a reconstituted-translation system using ICs 
programmed with an fMPPPF coding mRNA (Figure 22A). 
 
Figure 22: Effect of the modification of EF-P on peptide bond formation. 
A) Activity of differently modified EF-P. Formation of fMPPPF in an in vitro translation system in 
the presence of saturating EF-P (4 µM). 
B) The time resolved reaction of POST(fMPP) with Gly-TC catalyzed by sub-saturating 




In the presence of fully modified EF-P 60% of the substrate reacted to the fMPPPF 
product Figure 22A). In agreement with previously reported data (Doerfel et al., 2013; 
Ude et al., 2013), the unmodified EF-P showed a reduced activity and yielded 40% of 
product. The EF-P variant K34A was initially reported to have a similar activity as 
unmodified EF-P (Ude et al., 2013). However, the translation assay showed no activity of 
EF-P K34A. Because the body of EF-P remained unchanged, the loss of activity results 
solely from the K34A exchange. However, the lack of modification did not change the rate 
of the puromycin reaction at sub-saturation EF-P concentrations (Figure 22B). Under 
sub-saturating conditions the observed reaction rate is sensitive to catalytic and binding 
contributions. The reaction rate was 0.08 ± 0.01 s-1 in both cases. In the absence of EF-P a 
reaction rate of about 0.01 s-1 was reported, while under saturating concentrations of 
modified EF-P a reaction rate of about 1.3 s-1 was reported (Doerfel et al., 2013). Thus, the 
modification has only a minor contribution to binding, consistent with the conclusions 
presented in section 2.2.3. 
We planned to use the catalytically inactive EF-P variant K34A in pulsed-chase 
experiments, to better understand the correlation between EF-P dissociation and assisted 
catalysis. This experiment addresses the question, whether the mechanism of EF-P 
facilitated peptide bond formation in one run- or requires several association events. 
However, the experiment failed. Because we showed that EF-P (K34A) is catalytic inactive, 
it is likely that the equilibrium dissociation constant of EF-P (K34A) was significantly 
underestimated. Notably, EF-P (K34A) was considered sofar as an equivalent of 
unmodified EF-P (Mohapatra et al., 2017; Ude et al., 2013). However, in this study and in 
collaboration with the Wilson group we could show that EF-P (K34A), in contrast to 
unmodified EF-P, is completely inactive (Huter et al., 2017). Hence, we investigated why 
EF-P (K34A) appears to be catalytic inactive and followed up on the potentially 
underestimated Kd.  
In order to determine the binding affinity of EF-P K34A to the ribosome a 
EF-P(QSY) (K34A) labeling variant was established, and used in the EF-P binding assay 
(chapter 0). Surprisingly, with increasing concentration of labeled EF-P K34A no change in 




Figure 23: Characterisation of EF-P K34A. 
A) EF-P binding assay using EF-P(QSY) (K34A). Experiments were carried out with IC(Alx) 
(0.05 µM) and increasing concentrations of EF-P(QSY) (K34A): 0.25 µM (ochre), 0.5 µM (green), 
1 µM (turquoise), 1.5 µM (blue) and 2 µM (purple). Buffer was used for the donor-only trace 
(grey). 
B) Titration of EF-P(QSY) (K34A) to IC(L33Alx) in a fluorimeter. The fluorescence change with 
increasing concentration of fully modified EF-P(QSY) (black), unmodified EF-P(QSY) (grey) and 
EF-P(QSY) (K34A) (red) in equilibrium was plotted. The in equilibrium dissociation constant Kd 
was calculated using a quadratic equation. 
C) Equilibrium binding of EF-P(Alx) (K34A) to ICs monitored as a change of fluorescence 
anisotropy with increasing concentration of ICs, fitted with a quadratic equation. Black: 
EF-P(Alx) and red: EF-P(Alx)(K34A). 
 
Because the obtained traces reflect the fluorescence donor trace, it is likely that EF-P 
K34A does not bind to the ribosome. In order to verify this finding, an equilibrium 
titration IC with EF-P(QSY) was performed. While modified and unmodified EF-P(QSY) 
showed a concentration-dependent reduction of the fluorescent signal, the addition of 
EF-P(QSY) (K34A) did not to change the fluorescent signal (Figure 23B). This supports the 
conclusion that EF-P(QSY) (K34A) might not bind to the ribosome. To exclude that the 
FRET-based binding assay fails to report on EF-P(QSY) (K34A) binding, an alternative assay 
was used to study binding. EF-P (K34A) was labeled with Alexa Fluor™ 488 and used for 
anisotropy measurements. Initiation complexes were titrated with EF-P(Alx) (K34A) and 
the anisotropy was monitored. While the anisotropy of EF-P(Alx) increased with an 
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increasing concentration of IC, no change in anisotropy was observed using 
EF-P(Alx) (K34A) (Figure 23C). The measured anisotropy values for EF-P(Alx) (K34A) reflect 
the unbound state, with a high degree of rotational freedom of the dye. In conclusion, 
EF-P K34A does not facilitated peptide bond formation because it does not bind to the 
ribosome. In addition, the thermostability of EF-P (K34A) was compared with EF-P (wt) 
and EF-P (D66C) by ProteoPlex analysis. The preliminary analysis of EF-P variant K34A 
showed a reduced thermostability, whereas EF-P (wt) and the labeling variant D66C 
showed the same and higher thermostability (section: 5.4, Figure 30). These finding 
suggest, that EF-P (K34A) might be impaired in its fold. Taking these results together 
indicates that the body of EF-P is less important than expected and highlights the crucial 
role of Lys K34 for the activity of EF-P. 
 
2.3.3 The ribosomal protein L1 
Finally, we tested the role of L1 in the ability of EF-P to rescue translation on poly(Pro) 
sequences. ICs (wt and ΔL1) programmed with an mRNA encoding fMPPPF were mixed 
with the components of the translation system and EF-P and the product yield was 
measured after 30 s. With IC (wt) about 90% of the complexes produced the fMPPPF 
product, while with IC (ΔL1) 60% of the complexes formed the product (Figure 24A). This 
result may indicate that ribosomes lacking L1 are somewhat less active in EF-P-dependent 
translation or the activity of EF-P is compromised. Next, the puromycin assay was used to 
determine the activity at sub-saturating conditions of EF-P allowing binding effects to 
contribute to the reaction rate. With IC (wt) 80% of the complexes formed the fM-Pmn 
product, while with IC (ΔL1) only 20% of the complexes formed the product (Figure 24B). 
A smaller amplitude can result from side reactions, such as peptidyl-tRNA drop-off, or 
from a reduced activity of ribosomes lacking L1. The drop-off is unlikely to occur on ICs at 
the time scale of the experiment. The reaction rates were 0.43 ± 0.04 s-1 for IC (wt) and 
0.12 ± 0.02 s-1 for IC (ΔL1), which is nearly 4-fold slower in the absence of L1. Because the 
deletion of L1 was reported to have no effect on the rate of in vitro translation(reviewed 
in: (Tobin, 2011)), hence these findings show that EF-P is less active in the absence of 
ribosomal protein L1. In order to verify these findings, the variants EF-P D145L and T146A, 
which in previous experiments showed the same activity as EF-P (wt), were tested in the 
puromycin assay using IC (ΔL1). Independent of the used variants very similar product 
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amplitudes were obtained (Figure 24C), which match the product amplitude for IC (ΔL1) in 
Figure 24B. In line with that, also the reaction rates were the same (kobs of 
roughly 0.01 ± 0.02 s-1). 
To test the kinetic effect of L1 on EF-P activity upon synthesis of the natural 
EF-P-dependent motif fMPPG, we mixed Post(fMPP) (wt) or Post(fMPP) (ΔL1) with 
sub-saturating concentrations EF-P and TC-Gly (Figure 24D). With Post(fMPP) (wt) the kobs 
value of synthesis was 0.077± 0.009 s-1 (Figure 23D). When L1 was lacking, the rate was 
reduced by 10-fold to 0.008 ± 0.001 s-1. The modification of EF-P did not have an effect at 
the given conditions. The reduction of the reaction rate in the absence of L1 could 
potentially result from an altered binding of EF-P. This suggests that L1 is required for a 
preceding macroscopic positioning of EF-P, which in turn allows the modification to 
contribute to catalysis. However, we showed that the Kd of EF-P binding to the ribosome 
was independent of L1. A more likely explanation is that L1 is involved in the correct 
positioning of EF-P, which in turn results in a productive conformation of the 
nascent-chain and the CCA-end of the tRNA. Overall, these findings indicate that L1 is not 






Figure 24: EF-P activity on ribosome lacking L1. 
A) Translation efficiency. IC (wt or ΔL1) programmed with mRNA encoding fMPPPF were mixed 
with the components of an in vitro translation system including EF-P (2 µM). 
B) Effect of L1 on EF-P-dependent peptide bond formation. Time courses of puromycin reaction 
was measured in the presence of sub-saturating concentrations of EF-P (0.5 µM), supplemented 
with either IC (wt, black) or IC (ΔL1, grey) using a quench-flow apparatus. 
C) fMet-puromycin reaction on IC (ΔL1) in the presence of EF-P domain III loop I variants. The 
experiments were performed as in B with EF-P (wt) black; EF-P (D145L), blue; and EF-P (T146A), 
green. 
D) Catalysis of PPG synthesis with native and ΔL1 ribosomes. The reaction of Post(fMPP) with 
Gly-TC, was performed in the presence of sub-saturating concentrations of EF-P (0.5 µM) in a 
quench-flow apparatus. The following combination of post-complexes and EF-P were tested: 
Post(fMPP) (wt) in the presence of fully modified EF-P (black) and unmodified EF-P (grey), and 
Post(fMPP) (ΔL1)in the presence of fully modified EF-P (dark red) and unmodified EF-P (light red). 
 
 Biochemical characterization of the EFP-like protein 2.4
The reported modifications of EF-P cover only 31% of all sequenced bacterial genomes. 
For the remaining 69%, no homologs of known EF-P modifying genes were found. This 
leaves space for the existence of yet undescribed alternative modification and even EF-P 
paralog factors. In some cases bacteria have either an incomplete set of modifying 
enzymes, multiple isoforms of EF-P or no copy of the EF-P gene. This indicates that the 
necessity of the post-translational modification might be overcome by specialized EF-P 
orthologues (reviewed in: (Lassak et al., 2016; Rajkovic and Ibba, 2017)). One of these 
suggested EF-P paralogs is the E. coli EFP-like protein (YeiP) (Richards et al., 2012), which 
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is also found in other gamma-proteobacteria. The EFP-like protein is 190 aa long, shares a 
large similarity with EF-P and together they form the “elongation factor P” family of 
proteins. Interestingly, no data on the structure or function of EFP-like protein is available 
at present. Literature only describes the turn-over of the EFP-like protein mRNA, which 
showed no feedback regulation by the protein level itself (Richards et al., 2012). For both, 
efp and yeiP, the same mRNA half-time of 1.6 min was reported. Despite the similar 
mRNA half-times they seem to be subject to different degradation mechanism, because 
only yeiP was shown to be targeted by the RNA pyrophosphohydrolase RppH, whereas 
efp is not (Deana et al., 2008). It has been suggested that EF-P isoforms exists and the 
EFP-like protein might be one of them ((Richards et al., 2012) and reviewed in: (Lassak et 
al., 2016; Rajkovic and Ibba, 2017)). This is supported by the structural models which 
share a great similarity with EF-P (Figure 25A). This prompted us to test whether EFP-like 
protein can replace EF-P in protein synthesis. The key characteristics of EF-P are its ability 
to stabilize the P-site peptidyl-tRNA and to facilitate peptide bond formation between 
suboptimal substrates (Doerfel et al., 2013; Doerfel et al., 2015). For these studies, two 
tagged variants of the protein were prepared, the N- and C- terminally His-tagged EFP-like 
protein (EFP-like N and EFP-like C). 
The ability of the EFP-like protein to stabilize the P-site peptidyl tRNA was tested in an 
in vitro translation system, using ICs programmed with mRNA coding for fMPPG. The 
peptidy-tRNA drop-off was monitored by the amount of peptidyl-tRNA which remained 
bound to the ribosome in the presence or absence of EF-P and EFP-like protein (Figure 
25B). In presence of EF-P, 90% of peptidyl-tRNA was stably bound to the ribosome, 
whereas inthe absence of EF-P only about 40% of the peptidyl-tRNAs remained bound. 
The presence of N-terminally tagged EFP-like protein did not stabilize peptidyl-tRNA to a 





Figure 25: Binding and catalytic activity of the EFP-like protein in comparison to EF-P. 
A) Structural comparison of EFP-like protein and EF-P. The structure of the E.coli EFP-like proteins 
was simulated by SwissModel, using the EF-P X-ray structure [PDB 1ueb.1A] as template. Cryo-EM 
structure of E. coli EF-P [PDB 6ENU]. 
B) Stabilization of the P-site peptidyl-tRNA by EF-P(wt) and EFP-like protein variants carrying 
either a N- or C-terminal His-tag. The ability to reduce peptidyl-tRNA drop-off was monitored by 
quantification of of ribosome-bound peptidyl-tRNAs by scintillation counting of [
3
H]fMet. 
C) Comparison of the ability of EFP-like protein and EF-P to alleviate poly(Pro)-induced ribosome 
stalling. Initiation complexes programmed with an mRNA encoding fMPPG were used in an 
in vitro translation system lacking EF-P, or substituted with EF-P or either of the EFP-like protein 
variants. The product formation was monitored by [
3
H]Gly incorporation. 
D) Binding by the EFP-like variants and EF-P. The binding was monitored in chase experiments 
using EF-P and the EFP-like variants as chaser. EF-P(QSY) was pre-bound to IC(L33) and rapidly 
mixed with an excess of non-labeled EF-P (red), N-terminally (brown) and C-terminally tagged 
EFP-like protein (pink) or with buffer (black). The binding of EF-P(QSY) to IC(L33Alx) is shown in 
ochre and the donor only trace in grey. 
 
To follow up on the potential ability to stabilize the peptidyl-tRNA, it was investigated 
whether the EFP-like protein is able to rescue translation of a poly(Pro)-stalled ribosomes, 
the key function of EF-P. For that, the product formation of fMPPG was monitored, using 
an in vitro translation system in the presence and absence of EF-P and EFP-like protein 
(Figure 25C). In the presence of EF-P 50% of the complexes produced the fMPPG peptide. 
In the absence of EF-P no product (10% of the complexes formed the product). 
Supplementing the translation system with either of the EFP-like protein variants led, 
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compared to the absence of EF-P, to no increase in product formation. The efficient 
formation of fMPPG is EF-P dependent (Doerfel et al., 2013) and the EFP-like protein did 
not compensate for the absence of EF-P it failed to rescue poly(Pro) induced stalling and 
hence, product formation. 
Because, the EFP-like protein did not show any of the tested functions of EF-P, the 
question was raised, whether the EFP-like protein can bind to the ribosome. To address 
this question, both EFP-like protein variants were used in the EF-P binding assay as a 
chaser using a 20-fold excess (Figure 25D). The ability to hinder the re-association of 
EF-P(QSY) would indicate the ability of the EFP-like protein to bind to the ribosome. In the 
absence of any chaser an increase of the relative fluorescent from 0.9 to 1 was observed. 
Using unlabeled EF-P as chaser, resulted in an increase of the relative fluorescent from 
0.8 to 1. Using either of the EFP-like protein variants as chaser, resulted in an increase of 
the relative fluorescent from 0.9 to 1. This resembles the trace without a chaser, 
suggesting that neither of the variants acted as a chaser. The regain in relative 
fluorescence is likely to result from EF-P(QSY) dissociation and reduced re-association, 
due to the dilution of the complexes in the experiment. These results indicates, that the 
EFP-like protein either has a very high KD, hence the used excess was too little to act as a 
chaser or EFP-like protein does not bind to the ribosome. Our findings suggest that 
despite EFP-like proteins structural similarity to EF-P, it is no substitution for EF-P. 
Considering, that the model of EFP-like protein was created on the base of an EF-P X-ray 
structure, which is likely to bias the outcome of the simulation towards an “EF-P like” 
structure, questions the relation between EF-P and EFP-like protein even more. 
Nevertheless, none of the functional characteristics of EF-P were found for the EFP-like 
protein, neither the ability to binding to the ribosome, nor the stabilization of the P-site 
peptidyl-tRNA or the ability to alleviate poly(Pro) induced translational stalling. Hence, the 
role of the EFP-like protein remains still unknown. 
 
 Mass-spectrometric quantification of EF-P in the cell 2.5
To understand catalysis and binding of EF-P in the context of translation, it is important to 
know its cellular concentration. Different copy numbers were reported for EF-P. Early 
studies relying on 2D gel-electrophoresis and radioactive labeling suggested 5,000 copies 
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of EF-P per E. coli cell (An et al., 1980). A more recent mass spectrometric work suggests 
up to 40,000 copies of EF-P per cell depending on the growth conditions (Schmidt et al., 
2016a). However, ribosomal proteins are challenging for such label-free quantifications, 
which have the assumption that after proteolysis the peptides of all proteins have a 
similar oberservability. Due to their specific environment within the ribosome they share 
little similarities with cytosolic proteins. In comparison to other proteins they are small 
and contain over-proportionally many lysine and arginine residues. The high abundance 
of these trypsin cleavage motifs results in a high abundance of very short tryptic peptides 
which are difficult to detect by mass spectrometry. As a result the reported 
concentrations for ribosomal proteins are not equimolar but scatter over orders of 
magnitude (Schmidt et al., 2016a). This prompted us to remeasure the concentration of 
EF-P relative to the ribosome. To account for such for such sequence specific differences 
we decided to establish correction factors and apply them to our label free mass 
spectrometric results. In two constructs EF-P was fused with an individual representative 
ribosomal proteins. Here the ribosomal proteins L4 and L17 were used (Figure 26A). After 
proteolysis, the fusion proteins guarantee an equimolar ratio of the peptides derived 
from EF-P and the used ribosomal protein in the mass-spectrometric analysis. Observable 
peptides for the correction factors were identified by untargeted data-dependent 
acquisition (DDA) and for more consistent quantifications in the lysate targeted by 
parallel reaction monitoring (PRM). The integrated areas of the peptide fragments were 
used to calculate individual correction factors between the observed ribosomal and EF-P 
peptides. These correction factors were applied to the corresponding peptide intensities 




Figure 26: Mass-spectrometric quantification of EF-P. 
A) Used fusion proteins. 
B) Calculated ratio of EF-P to the ribosome based on ribosomal protein L17 and L4. 
C) Individual stoichiometries between selected peptides EF-P and ribosomal peptides. 
 
Average ratio of about 0.3 copies of EF-P per ribosome was determined. However, 
plotting the calculated ratio for the individual fragments revealed two sub-populations. 
One population shows a ratio of about 0.2 and the second population a ratio of about 0.4. 
These differences are likely to arise from the fact that only two EF-P peptides could be 
reproducibly detected in the lysate which led to these slightly deviating quantification. 
Nevertheless, our finding of about of 0.3 ± 0.1 copies of EF-P per ribosome is consistent 




The catalytic mechanism of EF-P is well understood (Doerfel et al., 2013; Doerfel et al., 
2015; Glick et al., 1979; Glick and Ganoza, 1975; Huter et al., 2017; Katoh et al., 2016; Ude 
et al., 2013). When the ribosome encounters a run of Pro codons, it stalls after 
incorporation of the second proline and requires the help of EF-P to resume translation 
(Doerfel et al., 2013; Peil et al., 2013; Ude et al., 2013). These conclusions, which were 
initially obtained in vitro, are in the meantime supported by in vivo ribosome profiling 
data (Woolstenhulme et al., 2015). However, it remains unclear under which 
circumstances EF-P binds to the ribosome during translation, and whether EF-P is 
recruited to its target complexes. Here, we established an in vitro EF-P binding assay to 
study the dynamics of EF-P in its functional context, and to dissect which of its 
interactions are important for the recognition of substrate complexes. 
The advantage of such an in vitro assay is the capability to break down the complexity 
of the reaction mechanism into individual kinetic steps, which can be studied separately. 
An example of such an approach is the dissection of translocation into multiple separately 
observed, loosely coupled events (Reviewed in: (Belardinelli et al., 2016b)), or of the 
mRNA decoding into a series of reversible and irreversible steps resulting in the 
incorporation of an amino acid into the nascent chain (Mittelstaet et al., 2011; Ranjan and 
Rodnina, 2017; Wohlgemuth et al., 2011; Wohlgemuth et al., 2010). Such work not only 
results in a conclusive overall mechanism, but also provides information about stable 
intermediate states which can be then isolated and their structure solved by e.g. 
cryo-electron microscopy or X-ray crystallography (Fischer et al., 2015; Ogle et al., 2001; 
Ogle et al., 2002; Schmeing et al., 2005; Schmeing et al., 2009; Voorhees et al., 2010; 
Weixlbaumer et al., 2008). The disadvantage of an in vitro system is the necessity to 
extrapolate the results to the in vivo context, where the observed step might undergo 
regulation or very different concentrations of the interaction partners are found 
((Schavemaker et al., 2017) and reviewed in: (Rivas and Minton, 2016)). The proper 
extrapolation to the conditions in the cell requires that the in vitro translation system 
works at in vivo-relevant rates and with a fidelity similar to translation in vivo. Our 
translation system fulfills this requirement (Mercier and Rodnina, 2018; Rudorf et al., 
2014). Furthermore, mathematical analysis of translation revealed that the rate constants 
derived at in vitro conditions can be extrapolated to in vivo conditions, and may be used 
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to simulate complex experimental time courses of protein synthesis in vivo (Rudorf et al., 
2014). Thus, it is likely that the elemental rates of individual EF-P interaction steps 
obtained from the in vitro system can be used to estimate the ribosome occupancy of 
different ribosome complexes during translation in cells. One of the main questions 
concerning EF-P binding is whether EF-P stochastically samples all ribosomes or whether 
certain structural recognition elements target EF-P to Pro-stalled ribosomes, and if so, 
how such a targeting could be regulated. 
In contrast to other elongation factors such as EF-G and EF-Tu, EF-P is not required for 
each round of translation elongation. It has a highly specific functional context and assists 
the ribosome during translation of poly(Pro) motifs. Proline is a poor A- and P-site 
substrate (Doerfel et al., 2013; Muto and Ito, 2008; Pavlov et al., 2009; Wohlgemuth et 
al., 2008), causing the rate of peptide bond formation to be reduced to such an extent 
that the translation of consecutive proline codons results in the stalling of translation. By 
specifically stimulating the peptide bond formation between a di-prolyl-peptidyl-tRNA 
and a slow A-site substrate, EF-P alleviates the poly(Pro)-induced translational stalling and 
allows translation to proceed (Doerfel et al., 2013; Peil et al., 2013; Ude et al., 2013; 
Woolstenhulme et al., 2013). Because the function of EF-P is context dependent, it is 
likely that poly(Pro)-stalled ribosome complexes provide EF-P recognition motifs. These 
binding determinants would allow EF-P to discriminate between complexes requiring 
assistance and those which do not. X-ray crystallographic and recent cryo-electron 
microscopic studies have shown that EF-P binds the ribosome between the E and P site 
(Blaha et al., 2009; Huter et al., 2017), making a vacant E site the prerequisite for EF-P 
binding that also kinetically controls the function of EF-P. In vivo studies showed that for 
other stalling events, EF-P had a negligible effect (Hersch et al., 2013; Woolstenhulme et 
al., 2013), either because no binding determinants were displayed or because EF-P does 
not alleviate the stalling at those sequences. To answer this question, a better 
understanding of EF-P binding is needed. This can be achieved by dissecting the 
contribution of each EF-P interaction element to binding and the activity of EF-P. 
Structural studies showed that the conserved GDT-motif of the flexible loop I of 
domain III is within hydrogen bonding distance of the E-site codon (Huter et al., 2017). 
This indicates that the E-site codon may act as a recognition element providing a specific 
functional context during stalling on Pro-codon stretches. In fact, poly(Pro)-induced 
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stalling occurs after incorporation of a second proline, hence poly(Pro)-stalled complexes 
always display a proline codon in the vacant E site and a peptidyl-tRNAPro in the P site. In 
contrast to EF-P, eIF5A lacks domain III and hence cannot interact with the E-site codon. 
Thus, the putative interactions between loop I of domain III of EF-P, even if they exist, are 
not evolutionary conserved. The recognition of specific codons has already been reported 
for release factors, which distinguish the stop codons using different peptide motifs (Ito 
et al., 2000). Proline is encoded by four codons of the CCN family and thus the flexible 
loop of domain III should recognize all four codons. We analyzed the affinity of EF-P 
variants, in which the residues contributing to the putative hydrogen bonds with the 
E-site codon were exchanged with hydrophobic residues. For the flexible loop EF-P 
variants which were tested, the affinity to the ribosome was not reduced (section 2.2.1). 
In a reverse experiment, the binding of EF-P (wt) to different codons was evaluated 
(section 2.2.1). We found no indication that EF-P could distinguish between proline and 
non-proline codons or that altered E-site codon can hinder EF-P binding, as it was 
suggested by molecular dynamics simulations (Huter et al., 2017). Although the affinity of 
EF-P for initiation complexes was not affected, some EF-P variants show a highly reduced 
FRET efficiency in the binding assay (section 2.2.1). Because the FRET efficiency depends 
on the distance between the FRET donor and acceptor, as well as the relative orientation 
of their dipole moments (reviewed in: (Clegg, 2002)), this reduction indicates a different 
conformation or orientation of the bound EF-P or the dyes, respectively. Consistent with 
these observations, the interaction of EF-P and the E site codon appears to that positions 
EF-P bound to the ribosome. For the activity of EF-P, however, the correct binding 
conformation might be essential, because EF-P stimulates peptide bond formation by 
positioning the peptidyl-tRNA in the peptidyl-transferase center in a catalytically active 
conformation (Doerfel et al., 2013; Doerfel et al., 2015; Huter et al., 2017). 
This prompted us to test the reaction between initiation complexes and puromycin in 
the presence of the previously described EF-P variants (section 2.3.1). We found that 
variants D145V and T146V show a 4-fold reduced reaction rate (0.12 s-1) in comparison 
with EF-P (wt) (0.43 s-1). To extend on this effect, EF-P variants with alternative E-site 
codon interaction surfaces to alleviate poly(Pro)-induced stalling and found that they 
have reduced activities (Huter et al., 2017). With a stepwise removal of the interaction 
elements the product level is stepwise decreased. The deletion of G145 shows no 
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reduction in its ability to alleviate poly(Pro)-induced stalling, likely because it has no 
side-chain which extends towards the mRNA and can contribute to a hydrogen bond. 
Notably, the disruption of all potential hydrogen bonds by exchanging all three conserved 
residues to alanine reduces the ability of EF-P to rescue translation by only 16%, whereas 
the deletion of G145 and T146 causes a reduction by 30%. The deletion of the entire 
GDT-motif and the upstream located amino acid resulted in the loss of activity, which was 
also observed for the deletion of the whole domain III. To analyze whether the E-site 
codon contributes to the activity of EF-P, we tested the reaction between initiation 
complexes displaying different E-site codons and puromycin (section 2.3.1). The absence 
of any rate differences (0.43 s-1 for Ile and Pro E-site codon) indicates that neither the 
binding nor the function of EF-P were impaired. This data suggests that there is a robust 
and non-specific interaction of EF-P and the E-site codon, which does not strictly rely on 
the residues D145 and T146. Because the binding kinetics of EF-P are not affected by the 
interaction of EF-P with the E-site codon, the disturbance of the binding interface, 
however, resulted in a decreased activity of EF-P. Thus, the E-site codon might position 
EF-P and thereby indirectly steer the peptidyl-tRNA into a catalytically-active 
conformation. 
The nature of the peptidyl-tRNA in the P site, or more specifically the D-arm of the 
tRNA, which is conserved in tRNAPro and tRNAfMet, is essential for the activity of EF-P and 
hence was suggested to be crucial for EF-P binding (Katoh et al., 2017a; Katoh et al., 
2016). So far we have only studied the binding of EF-P to initiation complexes, containing 
fMet-tRNAfMet, which provides a putative D-arm interaction. This prompted us to compare 
the binding kinetics of EF-P to initiation, Post(fMF), Post(fMP) and Post(fMPP) complexes 
(section 2.2.1 and 2.2.2). We found that EF-P has similar rates of association of about 40 
to 80 µM-1 s-1 for the tested complexes. However, the dissociation rate is highly affected 
by the nature of the complex and varied between 90 and 1 s-1. 
Interestingly, slower dissociation rates and therefore higher affinities of EF-P were 
found to correlate with its functional context. For Post(Phe) complexes we found an 
affinity of EF-P with a Kd of about 1 µM, while EF-P was reported to have a negligible 
contribution to reaction between POST(Phe) and puromycin (Doerfel et al., 2013). 
However, for initiation and POST(Pro) complexes, to which reaction with puromycin EF-P 
had a significant contribution, the affinity of EF-P was slightly increased by four-fold, to a 
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Kd of about 0.3 µM. For the poly(Pro)-stalled ribosome POST(fMPP), whose reactivity was 
reported to be almost dependent on EF-P (Doerfel et al., 2013; Peil et al., 2013; Ude et al., 
2013), the affinity was further increased 50-fold to a Kd of about 0.02 µM. These findings 
indicate that the binding of EF-P is, indeed, dependent on the nature of the 
peptidyl-tRNA. Despites its relevance for the activity of EF-P, the interaction of EF-P with 
the D-arm also appears to contribute to binding and helps to discriminate the functional 
context of EF-P. This would support a model in which EF-P samples all ribosome 
complexes with a vacant E site. The presence of tRNAPro or tRNAfMet in the P site allows for 
additional interactions, which are reflected in a 4-fold lowered Kd value. Surprisingly, 
although the complexes POST(fMP) and POST(fMPP) share the same tRNA body and thus, 
the D-arm, a 10-fold higher affinity of EF-P for POST(fMPP) complexes was found. This 
indicates that neither the tRNA, nor its D-arm or the amino acid proline, are sufficient to 
explain the additional stabilization of EF-P. However, the presence of a second proline 
residue in the nascent-chain reduces its flexibility (reviewed in section 1.3.1). The 
increased rigidity reduces the conformational space sampled by the nascent-chain, 
therefore reducing the likeliness to react with an A-site substrate. In the case of a 
diprolyl-moiety, not only is the rigidity increased, but also the conformation of the 
nascent-chain is altered to avoid clashes of the -2 proline with the ribosome (Huter et al., 
2017). In addition, molecular dynamics simulations predicted that the diprolyl-containing 
peptidyl-tRNA itself adopts an altered position and moves away from the A-site (Huter et 
al., 2017). Hence it appears likely that, while for the fMP-tRNAPro a classic 
post-translocation state can be assumed, fMPP-tRNAPro adopts an atypical strained 
conformation. This alternative positioning of the peptidyl-tRNA seems to provide specific 
EF-P binding interactions, resulting in a lower dissociation rate. Overall, it seems likely 
that the increased affinity of EF-P for poly(Pro)-stalled ribosomes depends on multiple 
interactions and is not based on the recognition of individual binding determinants. 
Interestingly, this mechanism seems not to be conserved for the yeast homolog of 
EF-P, eIF5A. In comparison to eIF5A, EF-P has a 20-fold lower affinity for initiation 
complexes (Table 5 & (Rossi et al., 2016)). The concentration of eIF5A in yeast is in a 
1:1 ratio with the ribosome, as found for factors involved in each round of translation 
(Kulak et al., 2014; von der Haar, 2008). The cellular concentration of EF-P is still a matter 
of discussion, with a suggested ratio of 1:10 (An et al., 1980; Schmidt et al., 2016a), 
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whereas our data indicates a 1:3 ratio. Both factors, eIF5A and EF-P, were initially 
discovered due to their ability to facilitate peptide bond formation between 
fMet-tRNAfMet and puromycin (Benne and Hershey, 1978; Glick et al., 1979; Glick and 
Ganoza, 1975; Schreier et al., 1977), apart from their function to alleviate 
poly(Pro)-induced stalling (Doerfel et al., 2013; Gutierrez et al., 2013; Ude et al., 2013). In 
contrast to EF-P, eIF5A was shown to have a more general role during translation (Gregio 
et al., 2009; Henderson and Hershey, 2011; Saini et al., 2009), due to its ability to alleviate 
non-poly(Pro)-stalled ribosome complexes and was also its involvement in peptide release 
(Pierson et al., 2016; Schuller et al., 2017). The broader substrate spectrum of eIF5A might 
be explained by structural data. The body of EF-P was found to be in extensive contact 
with P-site tRNA (Blaha et al., 2009; Huter et al., 2017), allowing for the recognition of the 
D-arm of tRNAPro and tRNAfMet by EF-P (Katoh et al., 2016). eIF5A however, did not show 
such interaction with the peptidyl-tRNA (Melnikov et al., 2016; Schmidt et al., 2016b). 
These findings further support the idea that EF-P discriminates its functional context 
according to the D-arm of the peptidyl-tRNA. 
The modification of EF-P plays an important functional role in vivo, as observed for 
the deletion strains of the modifying enzymes of EF-P (Abratt et al., 1998; Balibar et al., 
2013; Bearson et al., 2011; Navarre et al., 2010; Peil et al., 2013; Zou et al., 2012). The 
modification was proposed to increase the affinity of EF-P (Doerfel et al., 2013) to the 
ribosome. In the yeast homolog, the modified eIF5A was reported to have a 10-fold 
higher affinity than unmodified eIF5A (Rossi et al., 2016). Hence, we characterized the 
binding of unmodified EF-P to different post-translocation complexes (section 2.3.2). 
However, we found that the modification has no impact on the affinity of EF-P for 
different post-translocation complexes. The absence of the modification caused an 
approximately 2-fold reduction in the binding and dissociation rate of EF-P. From a steric 
point of view, a lower rate of binding appears counterintuitive. Considering that the 
modification of EF-P extends an already protruded lysine residue and EF-P has to bind in a 
specific and confined space within the ribosome, the binding should instead be hindered 
by such a modification, whereas a more compact unmodified EF-P should be able to bind 
faster. On the other hand, the modification contributes a positive charge, which could 
facilitate binding to the ribosome.  
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Aside from a putative contribution to binding, which we could not confirm, the 
modification of EF-P was identified as a main drive of EF-Ps entropic steering effect on 
peptide bond formation (Doerfel et al., 2013; Doerfel et al., 2015; Ude et al., 2013), 
suggesting that its main relevance lies in the catalytically active positioning of the 
peptidyl-tRNA. This is supported by molecular dynamics simulations which predicted that 
only in the presence of modified EF-P the carbonyl-carbon of the aminoacyl ester in the 
peptidyl-di-prolyl-tRNAPro and the α-amino group of the A site get into close proximity, 
assembling a catalytically active pre-attack conformation (Huter et al., 2017). In addition, 
the stabilization of the peptidyl-tRNA was shown to be independent of the modification of 
EF-P, further supporting its particular function in positioning the tRNAs in a catalytically 
active orientation. However, EF-P is modified in two separate steps, first the 
(R)-β-lysinylation of K34 and second the hydroxylation of K34 by EpmC. While we could 
shed more light on the relevance of the lysinylation, the relevance of the hydroxylation 
remains still elusive. 
Although the impact of EF-P hydroxylation on binding was not tested separately, our 
data suggest that none of the post-translational modifications has a significant impact on 
the binding kinetics of EF-P to the ribosome. Because the hydroxylation of EF-P neither 
contributes to the ability of EF-P to facilitate peptide bond formationy nor to binding, its 
relevance remains unknown. Its function might be deduced from its eukaryotic homolog, 
however. In yeast, the EF-P homolog eIF5A is first modified with deoxyhypusine, which in 
a proceeding step is transformed to hypusine (Park et al., 2010; Tong et al., 2009a; Wolff 
et al., 1990; Wolff et al., 2000). Interestingly, both modification levels showed the same 
ability to facilitate peptide bond formation, hence no further modification would be 
required (Park et al., 2011). However, because the first reaction is reversible, it was 
suggested that the second reaction removes the functional deoxyhypusine-modified 
eIF5A from the substrate-product pool of DHS and thereby prevents the backward 
reaction to an unmodified eIF5A (Park et al., 2003). A similar mechanism would be 
applicable for EF-P and its modifying enzymes, where the hydroxylation removes the 
(R)-β-lysinylated EF-P from the substrate-product pool of EpmA, thus preventing the 
backward reaction to unmodified EF-P. However, this assumption still needs to be proven. 
Surprisingly, the EF-P variant K34A, which was initially described as a functional homolog 
of unmodified EF-P (Ude et al., 2013) shows no activity and no affinity to the ribosome 
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(section 2.3.2). We obtained the same results for the EFP-like protein (section 2.4), which 
was suggested to be a functional paralog of EF-P ((Richards et al., 2012) and reviewed in: 
(Lassak et al., 2016; Rajkovic and Ibba, 2017)). Interestingly, the analogous mutation of 
K34A in yeast, K56A, resulted in more than 20-fold increase in the Kd, however, the 
authors did not comment on the stability of this eIF5A variant (Rossi et al., 2016). For EF-P 
(K34A) the loss of its binding ability likely results from its thermodynamic instability and 
the resulting impaired folding (section: 2.2.3). The same assumption could be drawn for 
EF-P variants with mutations in residues Y183 and R186, which also showed a complete 
loss of function upon alanine exchange. The thermodynamic instability of EF-P is further 
supported by studies which showed that EF-P is the dominant aggregate in the cell under 
various stress conditions in the absence of relevant chaperones (Tomoyasu et al., 2001). 
These findings propose that EF-P had to evolve such a thermodynamically-unstable fold to 
be able to achieve such high specificity. 
The question remains as to whether EF-P is actively recruited or whether its 
dissociation is guided by the ribosome. For deacalyted tRNAs the clearance from the E site 
is assisted by an interaction with the ribosomal protein L1 (Bock et al., 2013; Trabuco et 
al., 2010). The movement of L1 coincides with the rotation of the ribosome and with the 
different tRNA hybrid states (Cornish et al., 2009). Analogous to the L1-tRNA interaction, 
L1 was found to interact with the ribosome-associated EF-P (Blaha et al., 2009; Huter et 
al., 2017). Thus, L1 might be involved in the recruitment and/or dissociation of EF-P. Also 
for eIF5A the interaction with L1 was proposed to stabilize its binding (Barbosa et al., 
2016; Melnikov et al., 2016; Schmidt et al., 2016b). However, the binding affinity of EF-P 
to initiation complexes containing or lacking L1 is similar (section 2.2.4). Either the 
observed interactions between EF-P and L1 influences the binding and dissociation rates 
to the same extent or the favorable energy of L1–EF-P binding is compensated by losses in 
e.g. conformational freedom or solvation energy. However, L1 is important for 
EF-P-dependent catalysis of peptide bond formation, because in the absence of L1, the 
observed reaction rate is reduced 4-fold (section: 2.3.3). Thus, L1 is likely to be involved in 
the positioning of EF-P or the peptidyl-tRNA on the ribosome, and important for a 
catalytically active conformation. 
Compared to other translation factors, EF-P has neither a particularly high affinity for 
the ribosome, nor particularly fast or slow binding rates. For non-poly(Pro)-stalled 
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ribosome complexes, the binding and dissociation rates of EF-P are more similar to that of 
EF-Tu and EF-G than to initiation or release factors (Table 5), which have 10- to 100-fold 
higher affinities than EF-P (Hetrick et al., 2009). EF-G and EF-Tu are recruited to the A site 
of the ribosome by the ribosomal protein L7/L12 (Bock et al., 2013; Diaconu et al., 2005; 
Kothe et al., 2004) to form an initial binding complex. Comparing EF-P with other 
elongation factors shows that the association rates and the affinity of EF-Tu and EF-G in 
the initial complexes are similar to that observed for EF-P binding to e.g. the initiation 
complex (Rodnina et al., 1997; Rudorf et al., 2014). The similar rates of initial complex 
formation by different elongation factors may have evolved to support a high rate of 
translation elongation, in particular allowing for rapid scanning of different ribosome 
complexes by elongation factors. 
After initial binding, EF-Tu (as a part of the ternary complex with aa-tRNA and GTP) 
and EF-G are stabilized on the ribosome through specific recognition or engagement steps 
(reviewed in: (Belardinelli et al., 2016b; Wohlgemuth et al., 2011)). Such engagement 
steps proceed through the establishment of additional (or new) interactions. As a result, 
the apparent affinity of EF-Tu and EF-G is increased and the dissociation of EF-G and EF-Tu 
results from GTP hydrolysis and Pi release. Analogously, EF-P bound to the ribosome 
forms additional interactions with tRNAPro in the P site (section: 2.2.2 and (Huter et al., 
2017; Katoh et al., 2016)). In contrast to EF-G and EF-Tu, it has no regulating GTPase 
activity inducing dissociation. Notably, the spontaneous dissociation rate of EF-P from the 
functional complexes with fMPP-tRNA appears rather low, 1 s-1. One can envisage that 
during the ongoing translation, EF-P is actively removed from the E site during 
translocation by the P-site tRNA which moves through the E site on its way out of the 
ribosome. The release of EF-P could also be indirectly driven by the formed peptide bond, 
which relaxes the functional context resulting in a higher dissociation rate as found for 









Table 5: Binding kinetics of ribosome binding factors 
 kon [µM
-1 s-1] koff [s
-1] Kd [µM] Cellular conc. [µM] 
EF-P (modified) 71 25 0.3 5 – 20 i & j 
(unmodified) 42 9 0.2 ND 
EFP-like protein ND ND ND 1.3 k 
EF-G 140 a 70 0.2 10 
EF-Tu (initial binding) 175 b 700 4 90 – 100 h 
IF1 (30S IF3/IF2) 12 c 0.02 0.002 2.5 g 
IF2  




0.03 – 0.2 
3 g 
IF3 2 g 
RF1 (UAA binding) 34 d <0.1 < 0.0035 NA 
RF2 NA NA NA NA 
RF3 NA NA NA NA 
eIF5a (modified) NA NA 0.01 e 8–15 f 
(unmodified) NA NA 0.2 e NA 
EF-P rates are for POST(fMP), 
a
 (Rodnina et al., 1997), 
b
 (Rudorf et al., 2014), 
c
 (Milon et al., 2012), 
d
 (Hetrick 
et al., 2009), 
e
 (Rossi et al., 2016), 
f 
(Schuller et al., 2017), 
g
 (Bremer and Dennis, 2008), 
h
 (Maass et al., 2011), 
i
 (An et al., 1980) and 
j
 (Schmidt et al., 2016a) 
 
The binding of EF-P, as for most other translation factors, appears to be kinetically 
controlled. The kinetic window for EF-P binding is defined by the occurrence of a vacant 
E site, which normally does not occur during translation with an average speed of 10-20 
amino acids per second. At such speed of translation the E site will always be fully or 
partially occupied by a dissociating tRNA, which would hinder the binding of EF-P. 
Surprisingly, an in vivo study reported that 30% of EF-P co-localizes with the ribosome, 
which exceeds the expected frequency of poly(Pro)-stalling motifs in the E. coli, indicating 
that EF-P binds the ribosome also in the absence of proline-stalling motifs (Mohapatra et 
al., 2017). However, in a recent study it was shown that the average speed of translation 
is a statistical value that does not necessarily reflect the individual translation rates at 
codon resolution (Haase et al., 2018). Thus, individual slow elongation steps might lead to 
the occasional occurrence of a vacant E site. In addition to the potentially vacant E sites, 
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our data shows that the binding of EF-P is not restricted to its functional context. Hence, 
EF-P can also bind to other paused or stalled ribosomes without contributing to catalysis. 
EF-P-dependent stalled complexes remain associated with EF-P longer than those 
with a non-functional context. The comparison of the rates of EF-P accelerated peptide 
bond formation with the binding kinetics of EF-P reveals that at physiologic EF-P 
concentration its association is fast, while EF-P’s dissociation rates match the rate of 
peptidyl transfer. The reaction of POST(fMP) with TC-Gly, which is 10-fold accelerated by 
EF-P, proceeds in the presence of EF-P at 33 s-1 (Doerfel, 2016). EF-P binds to POST(fMP) 
at a rate of 71 µM-1 s-1 and dissociates at 25 s-1 (section 2.2.2). The primary functional 
context of EF-P, POST(fMPP), reacts with TC-Gly at a rate of 1 s-1, whereas EF-P binding 
occurs at a rate of 50 µM-1 s-1 and the dissociation occurs at 1 s-1 ((Doerfel, 2016) , section 
2.2.2). The correlation between the dissociation rates of EF-P and rate of EF-P-assisted 
peptide bond formation indicates that the dissociation of EF-P might be accelerated after 
peptidyl transfer by loss of its binding determinants. This finding also excludes the model 
of EF-P assisted catalysis in which EF-P has to bind multiple times to the stalled-complexes 
before the stalling is alleviated. Our data suggests that a single binding event is sufficient 
to position the peptidyl-tRNA in a catalytic active conformation, and that EF-P stays 
bound until peptide bond formation occurs. However, this conclusion is derived from 
in vitro data using complexes with a very short nascent chain and we cannot exclude that 
they adopt a state which does not fully reflect the in vivo situation. In the cell, the binding 
of EF-P might be influenced by other factors and we would find longer nascent chains. It 
was shown that the length and amino acid sequence of the nascent chain can have a 
significant effect on the translation rate and positioning of the nascent-chain itself 
(Reviewed in : (Rodnina, 2016)), (Huter et al., 2017; Katunin et al., 2002; Rudorf et al., 
2014)). 
In summary, we found that EF-P binds to all ribosome complexes that provide an 
empty E site, almost independently of the individual predicted interactions with tRNAPro 
or the E site codon. In non-stalling cases EF-P will rapidly dissociate from the ribosome 
with a rate that is compatible with translation elongation. However, in a poly(Pro) context 
the binding of EF-P is further stabilized. The resulting slow dissociation of EF-P matches 
the rate peptide bond formation of poly(Pro)-stalled ribosomes with slow A-site 
substrates. As a result the residence time of EF-P in poly(Pro)-stalled complexes is 
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increased and allows ribosome complexes to overcome stalling and proceed with 
elongation in a single run. After peptide bond formation, the strained complex might 
relax, thus lowering the affinity for EF-P. In this scenario EF-P would be recruited to stalled 
complexes and released after peptide bond formation, minimizing the impact of stalling 





4 Materials and Methods 
 Equipment and consumables 4.1
Table 6: List of equipment 
Device Supplier 
Acrodisc 25 mm Syringe Filter Pall Life Science  
ÄKTA FPLC GE Healthcare 
ÄKTA Explorer GE Healthcare 
Allegra X-22R centrifuge Beckmann Coulter 
Avanti J-26 XP centrifuge Beckmann Coulter 
Avanti J-30I centrifuge Beckmann Coulter 
Benchtop centrifuge 5415R and 5810R Eppendorf 
Bio-vision imaging system Peqlab Biotechnologie 
Cell densitity meter Ultrospec 10 GE Healthcare 
Cellulose nitrate filter, 0.45 µm, 25 mm Sartorius 
Amicon® Ultra 5 kDA cut-off Merck Millipore 
Digital sonifier cell disruptor W-250D Branson 
Dounce tissue grinder Wheaton 
Easy nLCII chromatography system Thermo Fisher Scientific 
Emulsiflex C-3 homogenizer Avestin 
Micro Time 200 PicoQuant 
FLA900 fluorescence imager Fuji Film 
ProteoPlex ProteoPlex GmbH 
HPLC Fluorescence detector 2475 Waters 
HPLC unit 2695 Waters 
HPLC UV/VIS detector 2489 Waters 
Innova 44 incubator shaker New Brunswick 
Intelli-mixer ELMI Ltd. 
JA-30.1 rotor Beckmann Coulter 
JLA-8.1000 rotor Beckmann Coulter 
Lambda Bio+ UV/VIS spectrometer Perkin Elmer 
Liquid scintillation counter TriCarb 3110 TR PerkinElmer 
Low retention 0.5 ml tubes Eppendorf 
D-Tube™ Dializer Midi, MWCO 3.5 kDa Merck Millipore 
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Milli-Q Advantage A10 Merck Millipore 
MLA-130 rotor Beckmann Coulter 
Nanodrop 2000 Peqlab Biotechnologie 
Optima XPN centrifuge Beckmann Coulter 
PCR Thermocylcer Peqlab Biotechnologie 
inoLAB Sentix81 WTW 
inoLAB pH720 WTW 
Plates incubator INE600 Memmert 
Q-Exactive hybrid mass spectrometer Thermo Fisher Scientific 
Q-Exactive Plus hybrid mass spectrometer Thermo Fisher Scientific 
Savant SPD111V SpeedVac Thermo Fischer Scientific 
SDS-PAGE electrophoresis chamber Bio-Rad 
SpeedVac vacuum concentrator SPD121P Thermo Fischer Scientific 
Stopped-flow cut-off filter KV500 Schott AG 
Stopped-flow SX20D spectrometer Applied Photophysics 
SX4250 rotor Beckmann Coulter 
Syringe filter: 0.2 µm & 0.45 µm Sartorius 
Thermomixer comfort Eppendorf 
Ti-50.2 rotor Beckmann Coulter 
TLA-100 rotor Beckmann Coulter 
TLS-55 rotor Beckmann Coulter 
TSQ Quantiva triple quadrupole mass spectrometer Thermo Fisher Scientific 
TSQ Vantage triple quadrupole mass spectrometer Thermo Fisher Scientific 
Ultimate 3000RSLC Thermo Fisher Scientific 
Ultracentrifuge Optima L-100 XP Beckmann Coulter 
Vivaspin® 20 5 kDa Sartorius 
Vortex Genie 2 Scientific Industries 
Water bath RE104 and E100 Lauda 
 
 Chemicals 4.2
All chemicals were purchased from Merck, Merck Millipore or Sigma Aldrich, if not 
indicated elsewhere. HPLC grade components were used for chromatographic separation. 
The dyes, enzymes and consumables used for this study are listed in Table 7. 
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Table 7: Dyes, enzymes and consumables 
Product Supplier 
AlexaFluor 488-mal Thermo Fisher Scientific 
AlexaFluor 655-mal Thermo Fisher Scientific 
Atto540Q-mal Atto-Tec 
BodipyFL-C1-IA Life technologies 
BSA Life technologies 
Chymotrypsin Thermo Fisher Scientific 
CMP Jena Bioscience 
cOmplete Protease Inhibitor EDTA free Roche 
DNase Jena Bioscience 
dNTPs New England Biolabs 
DpnI New England Biolabs 
Endoprotease – GluC Roche 
Endoprotease – LysC Roche 
GTP Jena Bioscience 
Irga-Safe Perkin Elmer 
NucleoSpin PCR cleanup kit Machery-Nagel 
NucleoSpin Plasmid kit Machery-Nagel 
Phusion Polymerase Thermo Fisher Scientific 
Proline Sigma Aldrich 
[14C]Proline Perkin Elmar 
Puromycin Sigma Aldrich 
Pyrophosphatase (PPase) Lucigen 
Pyruvate kinase Roche 
QSY-35-iodacetamide Life technologies 
QSY-7-maleimde Life technologies 
QSY-9-malimde Life technologies 
QuickZint 361 Zinnser Analytic 
RNAsin Promega 
T5 Exonuclease New England Biolabs 
T7 RNA polymerase New England Biolabs 
Taq DNA ligase Biozymes 
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Viomycin sulfate Fitzgerald 
 
 Chromatographic columns 4.3
The chromatographic columns used in this study are listed in Table 8. 
Table 8: List of columns 
Columns Supplier 
Chromolith®Performance RP-8e Merck 
HiTRAP Q 5 mL GE Healthcare 
HiTRAP HP SP 1 mL GE Healthcare 
LiChroCart 250-10, LiChrospher WP300 RP-18 Merck 
Protino Ni-IDA Resin Macherey-Nagel 
Protino column 35 ml Macherey-Nagel 
Reprosil-Pur 120 C18 3 µm column Dr Maisch 
Resource S GE Healthcare 
Superdex 75 10/300 GL GE Healthcare 
Superdex 75 Hiload 26/60 GE Healthcare 
 
 Software and applications 4.4
The software used for data acquisition, analysis and depiction are listed in Table 9. 
Table 9: List of software 
Software Provider 
Adobe Illustrator CS5 Adobe Systems 
CorelDRAW X7 Corel 
DNA Star Lasergene DNASTAR Inc. 
GraphPad Prism 5.0 GraphPad Software 
KinTecExplorer Pro 6.2.1 KinTek Corporation  
MATLAB The MathWorks 
MultiGauge 2.0 Fujifilm 
MaxQuant software 1.5.2.8 Max Planck Institute of Biochemistry 
Pymol 1.5 Schrödinger 
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Skyline 3.5 MacCoss Lab Software 
TableCurve 2D v5.01 Systat Software Inc. 
UCSF Chimera 1.10.1 Schrödinger 
Xcalibur 2.2 Thermo Fischer Scientific 
 
 Buffers  4.5
All buffers used in this study are listed in Table 10. 
Table 10: Buffers 
Buffer  Chemical composition 
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Aminoacylation buffer 50 
75 
35 




TK-labeling buffer 20 
100 






mM TRIS base pH 8.0 at RT 





mM TRIS-acetate pH 8.0 at RT 
mM EDTA 
 
SDS-PAGE running buffer 25 
200 
0.1 




SDS gel (de)staining solution 10 
5 
% ethanol 
% acetic acid 
(-)Coomassie blue 
 
 Bacterial and eukaryotic strains 4.6
All strains used in this study are classified in biosafety level BSL-1 and were handled 
accordingly. For genetic subcloning and molecular biology work the E. coli strains DH5α 
and NovaBlue were used. Protein overexpression was performed in E. coli BL21 (DE3) 
cells. Mass spectrometric proteome studies were based on E. coli MG1635, as well as S. 
cerevisiae S288C cells. Bacteria were cultivated in LB broth (10 g/L NaCl, 10 g/L tryptone 
and 5 g/L yeast extract) or on LB agar (LB broth substituted with 15 g/L agar). Yeast was 
cultivated in YPD medium (20 g/L glucose, 20 g/L peptone and 10 g/L yeast extract) or on 
YPD agar (YPD medium substituted with 18 g/L agar). 
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Table 11: Bacterial and eukaryotic strains 
Strain Genotype Company 
E. coli wt MG1655 DSMZ collection 
E. coli DH5α F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR 
nupG Φ80dlacZΔM15 Δ(lacZYA-argF)U169, 
hsdR17 (rK- mK+), λ– 
New England 
Biolabs 
E. coli BL21 (DE3) F– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI 
lacUV5-T7 gene 1 ind1 sam7 nin5]) 
New England 
Biolabs 
E. coli NovaBlue endA1 hsdR17 (rK12
– mK12
+) supE44 thi-1 recA1 
gyrA96 relA1 lac F′[proA+B+ lacIqZΔM15::Tn10] 
(TetR) 
Novagen, Merck 
S. cerevisiae S288C ATCC yeast 
collection 
 
 Molecular biology procedures 4.7
All primers were purchased from MWG or Eurofins. Kits for plasmid purification or PCR 
product purification were purchased from Machery Nagel. 
4.7.1 Polymerase chain reaction  
Phusion polymerase (2 units) in high-fidelity buffer and dNTPs (0.2 mM each) were used 
to amplify DNA from a template (0.6 ng µl-1) (Shampo and Kyle, 2002). The reaction mix 
was incubated in a thermocycler with an initial DNA denaturing step at 98°C for 3 min, 
followed by 33 cycles of denaturing at 98°C for 30 s, annealing at an appropriate 
temperature for 20 s and elongation at 72°C for 20 s per kb. For a colony PCR, half an 
E. coli colony was suspended in 20 µl water. For the PCR, 2 µl of the suspension were used 
as template. 
The PCR products were analyzed by agarose-gel electrophoresis and subsequent staining 
with Serva DNA stain G (Serva). If required, the desired PCR product was purified using 
either NucleoSpin Gel or PCR Clean-up Machery Nagel kit. 
4.7.2 Site-directed mutagenesis  
The Agilent QuickChange II Site-directed mutagenesis protocol was used to perform 
site-directed mutagenesis. Primers are listed in supplementary Table 16. 
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4.7.3 Site-directed mutagenesis using isothermal assembly 
An alternative method to perform site-directed mutagenesis was isothermal assembly 
(Gibson assembly) (Gibson et al., 2009). Two separate PCR products were produced 
overlapping by 18 nt at each end and together covering the whole plasmid. In both PCRs 
the desired nucleotide exchange was covered in either the forward primer of PCR 1 or in 
the reverse primer of PCR 2. The PCR products were purified with the NucleoSpin PCR 
cleanup kit and quantified photospectrometrically at a wavelength of 260 nm. Isothermal 
assembly was performed by mixing equal amounts of purified PCR products with T5 
exonulcease, Phusion polymerase, Taq ligase, dNTPs and dUTP diphosphatase followed by 
incubation for 25 min at 55°C. In order to remove the original template, the resulting 
products were treated with DpnI overnight at 37°C to digest methylated DNA. The 
primers used for Gibson assembly are listed in supplementary Table 16. 
4.7.4 Heat shock transformation 
Chemically competent cells were used for all transformations performed in this study. 
Cells (50 µl) were thawed in a water-ice mixture, 5 µl DNA solution was added and 
incubated for 30 min. The transformations were performed by applying a heat shock for 
45 s at 42°C. Subsequently, the cells were transferred back into the water-ice mixture and 
allowed to recover for 5 min. Prior to incubation for 60 min at 190 rpm and 37°C, 700 µl 
LB medium were added. The cell culture was centrifuged for 5 min at 3000 rpm, the 
supernatant discarded and the cell pellet resuspended in 100 µl LB medium. The 
resusupended cells were subsequently plated on LB agar supplemented with an 
appropriate selection antibiotic. Colonies were analyzed by colony PCR and Sanger 
sequencing (Seqlab). Plasmids carrying the desired base-exchange were extracted from 
the corresponding colony using the NucleoSpin plasmid purification kit (Macherey Nagel). 
 DNA constructs 4.8
The plasmid p00297 (pET28a +) for introducing mutations in EF-P was kindly provided by 
Christina Kothe (Max PIanck Institute for Biophysical Chemistry, MPI BPC). The plasmid 
encodes EF-P carrying an N-terminal 6xHis tag and its modifying enzymes EpmA, EpmB 
and EpmC, as well as a kanamycin resistance cassette. The sequences of ribosomal 
proteins was amplified from genomic DNA of E. coli MG1635 or S. cerevisiae S288C. 
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4.8.1 EF-P labelling variants 
Using the protocol from section 4.7.3 the following EF-P labeling variants were produced 
(Table 12). Cloning was kindly assisted by Christina Kothe. 
Table 12: EF-P labelling variants 
Plasmid EF-P variants 
pEF-P T3C T3C 
pEF-P M16C  M16C 
pEF-P S61C S61C 
pEF-P D66C (pOF0) D66C 
pEF-P A99C A99C 
pEF-P I100C I100C 
pEF-P N119C N119C 
pEF-P E134C E134C 
pEF-P S157C S157C 
 
4.8.2 EF-P functional variants 
To analyze the impact of modification at position K34 in EF-P, the corresponding genes 
epmA/B/C were deleted from the plasmid pOF0. In addition, to study a potential E-site 
mRNA codon interaction of EF-P, the following variants were made. 
Table 13: EF-P function variants 
Plasmid Mutation 1 Mutation 2 Mutation 3 Modifying enzymes 
pOF1 D66C D145L  YjeA, YjeK & YfcM 
pOF2 D66C D145V  YjeA, YjeK & YfcM 
pOF3 D66C T146A  YjeA, YjeK & YfcM 
pOF4 D66C T146V  YjeA, YjeK & YfcM 
pOF6 D66C Truncation*  YjeA, YjeK & YfcM 
pOF7 D66C Truncation*  YjeA & YjeK 
pOF11 EF-P wt   None 
pOF13 D66C   None 
pOF14 D66C D145L  None 
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pOF15 D66C D145V  None 
pOF16 D66C T146A  None 
pOF17 D66C T146V  None 
pOF18 D66C Truncation*  None 
pOF19 D66C K34A  None 
pOF22 D66C D145V K34A None 
pOF23 D66C Truncation* K34A YjeA, YjeK & YfcM 
pOF24 D66C K34A  YjeA & YjeK 
pOF25 D66C K34A  None 
pOF26 D66C Truncation* K34A None 
pOF27 D66C K34A  None 
* ΔL142,ΔK143,ΔG144,D145G,T146G,ΔA147, ΔG148, ΔT149 
4.8.3 EF-P fusion proteins 
For the mass spectrometric analysis of EF-P abundance in vivo (see chapter 2.5), reference 
proteins were made. The genes encoding the ribosomal proteins L4 and L17 were 
amplified from E. coli MG1635 genomic DNA and integrated into plasmid pOF13 yielding a 
L4/17-EF-P fusion protein. The same procedure was carried out for eIF5A and the 
ribosomal protein L4 which were amplified from S. cerevisiae S288C genomic DNA. The 
following EF-P/eIF5A fusion proteins were made (Table 4). The fusion proteins were 
purified as described in 4.10.1. 
Table 14: EF-P fusion proteins 





 RNA procedures 4.9
4.9.1 In vitro transcription of tRNAPro 
The template for in vitro transcription was made by PCR using the plasmid ptRNAPro, 
which was kindly provided by Dr. Lili Doerfel (MPI BPC). In vitro transcription was 
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performed in TRAB (see Table 10) with 10 µg/µl template, 10 mM DTT, 3 mM NTPs, 
5 mM CMP, 0.005 U*µl-1 PPase, 0.2 U*µl-1 RNAs-inhibitor and 1.6 U*µl-1 T7 polymerase 
(Sampson and Uhlenbeck, 1988) and incubated at 37°C for 3 h. The product was purified 
on a HiTRAP Q HP 5 mL column in 50 mM NaOAc pH 5, 10 mM MgCl2 applying a gradient 
up to 1.1 M NaCl. Fractions putatively containing tRNA were further analyzed by 
12% UREA PAGE. RNA was visualized by methylene blue staining. The product containing 
fractions were pooled and tRNA precipitated. The resulting pellet was dried in a speed-vac 
pump, resuspended in water and stored at -80°C. 
4.9.2 Denaturing polyacrylamide gel electrophoresis 
The transcription products were analyzed under denaturing conditions on a gel containing 
12% acrylamide (acrylamide/bisacrylamide 19:1), 8 M UREA, 100 mM Tris-borate, 
2 mM EDTA pH 8.3 and run in TBE buffer (Table 10). Polymerization of acryl/bisacrylamide 
was catalyzed by the addition of 0.1% tetramethylenediamine (TEMED) and initiated with 
0.005% ammonium persulfate (APS). Samples were incubated for 2 min at 95°C in loading 
buffer (0.1% bromphenol, 80% formamide and 0.1% xylencyanol in TBE). Prior to loading, 
the gel was pre-run for 15 min at 200 V. Samples were loaded and run at 50°C at 100 V 
until the sample entered the gel, with a subsequent increase to 200 V. The samples were 
fixed in the gel by incubation in 20% acetic acid until the bromphenol turns yellow. 
Staining was performed in a 0.04% methylene blue in 80 mM NaOAc pH 5 solution, 
followed by subsequent destaining in deionized water. 
4.9.3 Precipitation of RNA 
RNA was precipitated by the addition of 1/10 of the volume of 20% (w/v) potassium 
acetate pH 5.0, 2.5 volumes of ethanol and incubation at -20°C overnight. For the 
precipitation of low concentrated RNA, ethanol was replaced by one volume of 
propan-2-ol. 
4.9.4 Aminoacylation of tRNA 
Aminoacylation of tRNA was performed in aminoacylation buffer (Table 10) containing 
3 mM ATP and 1 mM DTT. To start the reaction, 1 µM prolyl-tRNA synthetase, 
0.5% inorganic pyrophosphatase, 25 µM tRNAPro and 60 µM [14C] Pro or 100 µM Pro were 
added and incubated at 37°C for 30 min. tRNA was purified by phenol extraction using 
2.5 volumes of phenol saturated by addition of 0.3 M potassium acetate (KOAc). After 
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rigorous mixing for 30 s, phase separation was facilitated by centrifugation at 4,500 rpm 
for 5 min at RT and the aquous phase collected. This procedure was repeated twice. In 
order to remove phenol traces from the aqueous phase, 2.5 volumes of diethyl ether 
were added, mixed on a vortex at maximum speed for 30 s, centrifuged at 4,500 rpm for 
5 min at RT and the organic phase removed. This procedure was repeated until no phenol 
traces at the inter-phase were visible. tRNA was precipitated as described in section 4.9.3 
and dissolved in water. Aminoacyl-tRNA was purified on a LithoChrome WP-300 RP18 
column in 20 mM ammonium acetate pH 5, 10 mM magnesium acetate, 400 mM NaCl 
and 5% ethanol, applying a gradient 0-15% ethanol over 85 min. Fractions containing 
isotopically labeled aa-tRNAs were identified by scintillation counting. Non-radioactively 
labeled aa-tRNAs eluted with the corresponding retention time. Fractions containing 
aa-tRNA were pooled and precipitated as described 0, dried in a speed-vac and dissolved 
in water. Radio isotopic-labeled proline allowed to determine the efficiency of 
aminoacylation by tRNA precipitation, nitrocellulose filtration and subsequent 
14C-scintillation counting taking into account the concentration of tRNA determined 
spectroscopically at A260. For aminoacylation with non-radioactive proline the efficiency 
was determined by the formation of a radio isotopically-labeled tri-peptide. Tritium 
labeled initiation complexes were used to translate fMPF, in which f[3H]Met and [14C]Phe 
were used as radioactive markers. The formed product correlates to the Pro-tRNAPro 
concentration (as described in 4.13.2). Aminoacylation and concentration determination 
of other isotopically labeled and unlabeled tRNAs, as well as the determination of the 
specific activity of 14C-Pro was kindly performed by Olaf Geintzer (MPI BPC). 
4.9.5 Synthetic mRNA constructs 
mRNAs were purchased from IBA Life Science. The constructs contain a strong 
Shine-Dalgarno sequence (G GCA AGG AGG U (Calogero et al., 1988)), which is followed 
by a linker (AAAUA) and the coding sequence. The chosen codons in this study represent 
the most abundant tRNA isoacceptors. In order to study the influence of the E-site codon 
on EF-P binding, in one construct the linker sequence was varied to AACCG. All mRNA 
constructs are listed in Table 15. 
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Table 15: mRNA constructs, with underlined start-codons 
Name Sequence 
fMGF G GCA AGG AGG UAA AUA AUG GGU UUC 
fMPFG G GCA AGG AGG UAA AUA AUG CCG UUC GGU AUU 
fMFPG G GCA AGG AGG UAA AUA AUG UUC CCG GGU AUU 
fMPGF G GCA AGG AGG UAA AUA AUG CCG GGU UUC AUU 
fMPPGFV G GCA AGG AGG UAA AUA AUG CCG CCG GGU UUC GUU 
fMPPPF G GCA AGG AGG UAA AUA AUG CCG CCG CCG UUC AUU 
profMFPGI G GCA AGG AGG UAA CCG AUG UUC CCG GGU AUU 
 
 Protein purification, labelling and stability 4.10
4.10.1 Expression and purification of EF-P 
In order to purify EF-P, the corresponding plasmid (To analyze the impact of modification 
at position K34 in EF-P, the corresponding genes epmA/B/C were deleted from the 
plasmid pOF0. In addition, to study a potential E-site mRNA codon interaction of EF-P, the 
following variants were made. 
Table 13) was transformed into E. coli BL21(DE3). A pre-culture was used to inoculate the 
main culture with a starting optical density (OD600) of 0.05. The cells were cultivated in 
LB medium supplemented with 0.5 µg/mL kanamycin at 37°C at 200 rpm shaking. The 
overexpression was induced at an OD600 of 0.5 to 0.8 by the addition of 
1 mM isopropyl β-(D)-1-thiogalactopyranoside (IPTG), activating the T7 RNA-polymerase 
lac promotor. After 3 h the cells were harvested by centrifugation at 9,600 x g for 30 min 
in a JLA8.1 Beckmann rotor mounted to an Avanti J-26 XP centrifuge (Beckman Coulter). 
The gained cell pellet was resuspended in 20 mM Tris-HCl pH 8.5, 300 mM NaCl, 
5 mM 2-mercaptoethanol, and 10% glycerol (Protino Buffer), supplemented with 
cOmplete protease inhibitors and DNase. The cells were opened by pressure using an 
Emulsiflex C-3 homogenizer (Avestin). The cell lysate was centrifuged for 30 min at 
300,000 x g in a JA25.30 Beckmann rotor mounted to an Avanti J-26 XP centrifuge 
(Beckman Coulter). The supernatant was cleared from insoluble particles by applying it to 
a 0.45 µm glass-fibre filter (Pall Life Science). Because the overexpressed EF-P possesses 
an N-terminal 6xHis-tag, immobilized metal ion affinity chromatography was used to 
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separate EF-P from the cleared lysate. The lysate was applied to a Protino Ni-IDA matrix in 
a gravity flow column and the manufacturer’s protocol was followed. EF-P was eluted in 
protino buffer supplemented with 250 mM imidazole. The eluate was concentrated using 
a Vivaspin® 20 5 kDa cut-off ultrafiltration unit. The resulting concentrate was further 
purified and the buffer exchanged by applying the protein solution to a size exclusion 
chromatography column (Superdex 75 HiLoad 26/60 GE Healthcare) using TAKM7 (see 
Table 10). The fractions showing an absorbance at 280 nm were analyzed on a 15% SDS 
PAGE. The fractions containing EF-P were pooled and concentrated in a 
Vivaspin® 20 5 kDa cut-off ultrafiltration unit. The concentration of EF-P was determined 
either by absorbance at 280 nm, assuming a calculated extinction coefficient of 
25,440 cm-1 M-1, or by densitometric quantification from the SDS-PAGE using a reference 
protein of known concentration. 
4.10.2 Expression and purification of EFP-like protein 
In order to purify the EFP-like protein the protocol as described in 4.10.1 was followed. 
Two EFP-like protein variants, being either N- or C-terminally 6xHis-tagged, were 
produced by Christina Kothe. The concentration of the EFP-like protein was determined 
by absorbance at 280 nm, assuming a calculated extinction coefficient of 18,910 cm-1 M-1. 
4.10.3 Sodium dodecyl sulfate polyacrylamide gel electrophorese (SDS-PAGE) 
Protein purity was analyzed by SDS PAGE (Laemmli, 1970; Weber et al., 1972). The 
standard resolving gel contained 15% acrylamide (29:1 acryamide/bisacrylamide), 
40 mM Tris-HCl pH 8.8 at RT and 0.1% SDS, whereas the standard stacking gel consisted of 
4% acrylamide (29:1 acryamide/bisacrylamide), 12,5 mM Tris-Hcl pH6.8 at RT and 
0.1% SDS. Polymerization of the gel solution was induced by the addition of 0.05% APS 
and catalyzed by 0.1% TEMED. To analyze the ribosomal protein L33, the concentration of 
Tris-HCl was doubled and acrylamide (29:1 acryamide/bisacrylamide) was increased to 
18%. Proteins were visualized by incubating the gel for 10 min in Coomassie staining 
solution (Table 10) and subsequent destaining with destaining solution (Table 10). 
For mass-spectrometric analysis, pre-casted Mini-PROTEAN®TGX™ BioRad gels were 
used. All SDS poly-acrylamide gels were run vertically in a BioRad gel system. 
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4.10.4 Labeling of EF-P 
Prior to labeling, EF-P was reduced with a 10-fold molar excess of DTT or TCEP for 30 min 
at RT shaking with 20 rpm. To avoid that the thio-reactive dyes reacts with the excess of 
DTT, the buffer was changed to TK buffer (see Table 10) using a G25 midi column 
(GE Healthcare) following the manufacturer’s spin protocol. TCEP is mostly unreactive and 
therefore is not required to be removed from the buffer. For dyes functionalized with a 
maleimide group, TK pH 8.3 and for iodacetamide functionalized dyes, TK pH 7.3 was 
used. The dyes were solved in dimethylformamide (DMF) to yield a final concentration of 
10 mM. While EF-P (100 µM) solution was mixed on a Vortex (Scientific Industries), the 
dye (final concentration 1 mM) was added dropwise and the reaction mix was incubated 
at room temperature protected from light for 2 h. The reaction was quenched by the 
addition of 10 mM 2-mercaptoethanol and centrifuged at 16,000 x g for 5 min in a bench 
top centrifuge (5415R Eppendorf). Free dye was removed by seize exclusion 
chromatography using either G25 midi columns following the gravity flow protocol or on a 
Superdex S75 10/300 GL (GE Healthcare) column. Fractions containing labeled proteins 
were analyzed spectrophotometrically at a wavelength of 280 nm and the corresponding 
maximum absorbance of the dye used. AleaxaFluor™ 488 (AF488) has the maximum 
absorption (λmax) at 495 nm and an extinction coefficient of ε = 73,000 cm
-1 * M-1. QSY-7 
has the maximum absorption at 560 nm and an extinction coefficient of 
ε = 90,000 cm-1 * M-1. QSY-9 has the maximum absorption at 562 nm and an extinction 
coefficient of ε = 88,000 cm-1 * M-1. QSY-35 has its absorbance maximum at 475 nm and 
an extinction coefficient of ε = 23,000 cm-1 * M-1. Atto540Q has its maximum absorption 
at 543 nm and an extinction coefficient of ε = 105,000 cm-1 * M-1. 
The degree of labeling (DOL) was calculated as described in Equation 1. 
Equation 1: Calculation of the degree of labeling. 




Amax is defined as the absorbance of the dye at λmax. εmax is defined as the extinction 
coefficient of the dye at the absorbance maximum. εProt is defined as the extinction 
coefficient at the absorption maximum of the dye. AProt
 is defined as described in Equation 
2, and CF280 is defined as described in Equation 3. 
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Equation 2: Calculation of the AProt. 
𝐴𝑃𝑟𝑜𝑡 =  𝐴280 − (𝐴𝑚𝑎𝑥 ∗ 𝐶𝐹280) 
Equation 3: Calculation of the correction factor CF280. 




The fractions with the highest DOL were pooled and used for this study. 
4.10.5 ProteoPlex analysis 
In order to investigate whether the introduced point mutations had an effect on the 
stability of EF-P, the commercially available ProteoPlex system was used (Chari et al., 
2015). Protein solution (18 µl) with a concentration of 5 mg/ml was mixed with 2 µl of 
SYPRO® Orange Protein Gel stain solution in a 96-well microtiter plate (Biozym) and 
applied to the ProteoPlex reader. As reference, four replicates of EF-P (wt) protein and 
two blanks of TAKM7 buffer and de-ionized water were used. 
4.10.6 Purification of the ribosomal protein L33 
The plasmid pET24A rpmG P31C encoding for the labeling variant of the ribosomal protein 
L33 (P31C) was kindly provided by Dr. Belardinelli (MPI BPC). The plasmid was 
transformed into E. coli BL21(DE3) and the protein expressed as described in chapter 
4.10.1. The cell lysate was centrifuged for 30 min at 300,000 x g in a JA25.30 Beckmann 
rotor mounted to an Avanti J-26 XP centrifuge (Beckman Coulter). The pellet was washed, 
dissolved and flash frozen in opening buffer (5 mM HEPES pH7.5, 200 mM KCl, 5% glycerol 
and cOmplete protease inhibitor). For cell lysis, the cells were thawed and applied to a 
Digital sonifier cell disruptor W-250D (Branson) using 8 pulses with an amplitude of 20% 
with a period of 20 s. The resulting cell lysate was centrifuged at 30,000 x g for 30 min, 
the supernatant was discarded since it mainly contains the undesired L33 wt protein. The 
desired L33 labeling variant was mainly found in the inclusion bodies. The pellet 
containing membrane and inclusion bodies was resuspended and stirred for 1 h at RT in 
50 mM HEPES pH 7.5, 50 mM KCl, 5% glycerol, 5 mM 2-mercaptoethanol and 6 M urea 
and further homogenized using a Dounce tissue grinder (Wheaton). The solution was 
centrifuged at 30,000 x g for 30 min. The supernatant was diluted 10-fold with 
50 mM HEPES pH 7.5, 5% glycerol, 5 mM 2-mercaptoethanol and 6 M urea and applied to 
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a 1 mL HiTrap SP HP cation exchange chromatography column (GE Lifescience). The 
separation of proteins was performed in 50 mM HEPES pH 7.5, 5% glycerol, 
5 mM 2-mercaptoethanol and 6 M urea with a gradient of 5 mM to 300 mM KCl over 
30 column volumes (CV). The fractions were analyzed by SDS-PAGE as described in 
chapter 0. Fractions containing L33 were pooled, diluted 10-fold and applied to a 
Resource S cation exchange column (GE Lifescience). The separation of proteins was 
performed in 50 mM HEPES pH 7.5, 5% glycerol, 5 mM 2-mercaptoethanol and 6 M urea 
with a gradient of 5 mM to 300 mM KCl over 30 column volumes (CV). Fractions 
containing L33 were pooled, flash frozen and stored at -80°C. 
4.10.7 Labeling and refolding of ribosomal protein L33 
Labeling of L33 was performed under denaturing conditions in the presents of 6 M urea. 
The concentration of L33 was adjusted to 100 µM and the protein was incubated with 
10 mM AlexaFluor488 (AF488) dissolved in DMF at RT in the dark for 90 min while 
rotating at 28 rpm. The reaction was quenched by the addition of a 10-fold excess of L33 
quenching buffer (25 mM HEPES pH 7.3, 30 mM KCl, 6 mM 2-mercaptoethanol, 
10% glycerol and 6M urea). In order to separate the labeled protein from free dye, the 
mixture was manually applied to a 1 ml HiTrap HP SP column. The flow-through was 
reapplied to the column. The free dye was removed by washing the column with 10 CV of 
quenching buffer. The L33-AF488 conjugate was eluted using L33 quenching buffer with 
300 mM KCl. In order to refold the L33-AF488 conjugate, the eluate was applied to 
multiple step dialysis. Using a 3.5 kDa cut-off midi D-tube dialyzer (Merck Millipore), the 
buffer was exchanged to L33 storage buffer (25 mM HEPES, 300 mM KCl and 
10% glycerol). In the first dialysis step the urea concentration was reduced to 4 M urea 
(4 h of incubation at RT). In the second step, the urea concentration was reduced to 
2 M urea (4 h at 4°C). In the third step, no urea was present in the buffer (o/n at 4°C). The 
refolded L33-AF488 conjugate was flash frozen and stored at -80°C. 
 Ribosome complexes and translation 4.11
4.11.1 Reconstitution of 50S subunits with the ribosomal protein L33 
Large ribosomal subunits lacking L33 were prepared according to (Peske et al., 2005; 
Rodnina and Wintermeyer, 1995) and kindly provided by Sandra Kappler (MPI BPC). 
Reconstitution using L33 labeled with AF488 was carried out using a 1.05 excess of L33 
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over 50S subunits in 50 mM HEPES pH 7.5, 400 mM KCl, 20 mM MgCl2, 
6 mM 2-mercaptoethanol and 10% glycerol for 1 h at 37°C (Belardinelli et al., 2016a). The 
sample was cooled on ice and centrifuged for 5 min at 16,000 x g at 4°C. To remove the 
excess of L33-AF488 the supernatant was transferred on a 30% sucrose cushion in TAKM7 
buffer, and centrifuged in an MLA-130 rotor for 2 h at 4°C at 385,900 x g. The supernatant 
was discarded and the centrifugation tube placed on ice. TAKM7 buffer was added onto 
the pellet and incubated for 10 min on ice. The pellet was dissolved by carefully tapping 
against the tube. The solution was centrifuged for 2 min with 16,000 x g at 4°C. The 
reconstituted 50S subunits were quantified photometrically at a wavelength of 260 nm 
(1 OD260 = 37 pmol) and 495 nm (ε = 73,000 cm
-1 * M-1); the ratio reflects the 
reconstitution efficiency. 
4.11.2 Assembly of 70S initiation and post-translocation complexes 
The assembly and purification of 70S initiation and post-translocation complexes was 
performed as described by Rodnina and co-workers (Belardinelli et al., 2016a; Rodnina et 
al., 1997). 30S subunits were activated by incubation in TAKM20 buffer for 30 min at 37°C. 
In order to assemble 1 µM 70S initiation complex, 1.5 µM 30S subunits were incubated 
with 3 µM mRNA, 2 µM IF1, IF2 and IF3, 2.5 µM f[3H]Met-/fMet-tRNAfMet and 1 µM 50S 
subunits in either TAKM7 or HiFi buffer containing 1 mM GTP for 30 min at 37°C. 
Subsequently, the reaction mix was cooled on ice for 5 min and centrifuged for 2 min at 
16,000 x g. The supernatant was applied to a 30% sucrose cushion in either TAKM20 or 
HiFi and centrifuged for 2 h at 4°C at 259,000 x g using a TLS-55 rotor. The pellet was 
resuspended in TAKM7 and the ribosome complexes quantified spectrophotometrically at 
a wavelengths of 260 nm (1 OD260 = 23 pmol). If applicable, initiation was quantified by 
nitrocellulose filtration and subsequent scintillation counting. Complexes that contained 
non-radioactive fMet-tRNAfMet were quantified by forming a radioactively labeled 
di-peptide. 
Post-translocations complexes were formed by the addition of the corresponding 
ternary complex in a two-fold excess over the codon concentration and incubation for 
2 min at 37°C. Ternary complexes were prepared by incubating the corresponding 
aminoacyl-tRNA with a 2-fold (in the case of proline 3-fold) molar excess of EF-Tu, 
1 mM GTP, 3 mM PEP, and 0.1 mg * ml-1 pyruvate kinase for 15 min at 37°C. The formed 
complexes were treated as described above. Initiation and post-translocation complexes 
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were also formed using purified 70S subunits kindly provided by Sandra Kappler. The 
formation of complexes was performed as described without prior ribosome activation 
step. 
 Binding kinetics of EF-P 4.12
All kinetic studies were performed at 37°C in HiFi buffer. 
4.12.1 Rapid kinetics of EF-P binding 
Rapid kinetic experiments of EF-P binding to the ribosome were performed in a SX-20MV 
stopped-flow apparatus (Applied Biophysics), which allows the rapid mixing of two 
solutions while monitoring fluorescence. 
 
Figure 27: Schematic depiction of the stopped-flow setup used in this study 
A stopped-flow apparatus allows to rapidly mix two solutions while acquiring optical changes in 
real time. The device has an approximate dead time of 1.5 ms and can be operated under 
temperature controlled conditions. After loading the fluorescent solutions into the 
corresponding syringes equal volumes are mixed and pass through an optical chamber until the 
flow is stopped by the stop-syringe. Depending on the used detectors FRET, anisotropy or light 
scattering can be monitored. In this study fluorescence changes resulting from FRET were 
monitored. 
 
To measure EF-P binding, ribosome complexes harboring L33-AF488 were excited at a 
wavelength of 470 nm and the emitted light was monitored after passing through a 
500 nm cut-off filter (KV-500). EF-P QSY-35 quenches the fluorescence of L33-AF488 
containing ribosome complexes upon coming in close proximity. Fluorescent ribosome 
complexes were used at a final concentration of 50 nM and were mixed with 
0.25 - 3 µM EF-P(QSY). Samples were prepared in 600 - 800 µl of HiFi buffer. Prior to 
loading, the samples were centrifuged for 2 min at 16,000 rcf at 4°C. One measurement 
required 60 µl of each sample and 7 to 10 technical replicates were acquired. From each 
rapid mixing experiment 5,000 logarithmically distributed data points were acquired. Each 
time course experiment was plotted in GraphPad Prism. The data was analyzed by 
two-exponential (Equation 4) with an additional term for a linear slope if needed 
(Equation 5) using TableCurve 2D v5.01.01 (Systat Software Inc.). 
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Equation 4: Two-exponential function 
f(X) = A + B ∗ EXP(−C ∗ X) + D ∗ EXP(−E ∗ X) 
Equation 5: Two-exponential function with the addition of a slope 
f(X) = A + B ∗ EXP(−C ∗ X) + D ∗ EXP(−E ∗ X) + F ∗ X 
4.12.2 Equilibrium kinetics of EF-P binding 
To analyze the binding affinity of EF-P for different substrates, an equilibrium EF-P 
titration was performed. Fluorescent ribosome complexes were titrated with EF-P QSY-35 
in a spectrofluorimeter. EF-P was added to 10 nmol ribosome complexes, mixed and 
incubated for 30 s at 37°C to reach equilibrium. Fluorescence was excited at 470 nm and 
the fluorescence emission was monitored at 530 ± 5 nm using a monochromator. The 
data points were fitted using a quadratic function (Equation 6) in GraphPad Prism. 
Equation 6: Quadratic function 
f(X) = A + B ∗ [(IC + X + Kd) − sqrt(sqr(IC + X + Kd) − 4 ∗ IC ∗ X)] 
4.12.3 Equilibrium kinetics using anisotropy 
For non-fluorescent ribosome complexes, the anisotropy of AlexaFluor 488 conjugated to 
EF-P was used to study the dissociation constants. 10 nmol of EF-P- AF488 were mixed 
with an increasing concentration of ribosome complexes and equilibrated for 30 s at 37°C. 
The anisotropy values were corrected for light scattering caused by the ribosome. The 
following equation was used to calculate the anisotropy: 
Equation 7: Calculation of anisotropy 
𝑟 =  (vv – (hv/hh) ∗ vh)/(vv + 2 ∗ (hv/hh) ∗ vh). 
Where (hv/hh) is an empirical correction factor accounting for a device- and 
wavelength-dependent polarization detection bias; vv and vh represents the measured 
intensities derived from the vertical excitation; hh and hv represent the measured 
intensities derived from the horizontal excitation. 
 Kinetics of EF-P facilitated catalysis 4.13
All experiments aimed at the role of EF-P in facilitating peptide bond formation were 
performed in HiFi buffer, if not stated elsewise. Time-resolved experiments were 
performed, as applicable, manually or using a quench-flow apparatus (Figure 28). 




Figure 28: Schematic depiction of a quenched-flow apparatus. 
A quenched-flow apparatus allows to rapidly mix two reactants and subsequently quench the 
reaction at desired times. First, equal volumes of the two reactants are mixed and allowed to 
react for a variable time (tx) at a given temperature. Then, a quencher is added, to stop the 
reaction. The dead time of the machine is approximately 2 ms. 
 
After quenching, the neutralized reaction mixes were loaded on a 
Chromolith® Performance RP8e 100-4.6 mm column using a Walters HPLC unit 2695. 
Separation of products and educts was achieved with a 0 to 65% acetonitrile gradient 
(depicted in Figure 29) in 0.1% TFA. Product yields were assessed via double-scintillation 
counting, plotted and fitted using a two-phase association model. 
 
4.13.1 Time-resolved puromycin reaction 
When puromycin was used as analog of the A-site substrate, a time-resolved puromycin 
reaction (Holtkamp et al., 2004) was performed. Purified initiation complexes were mixed 
with Pmn and sub-saturating concentrations of EF-P in a quench-flow apparatus. The 
reaction was quenched with 50% formic acid and ribosome complexes dissociated by 
adding 500 µl 1.5 M sodium acetate saturated with MgSO4. The formed products were 
extracted using 750 µl ethyl acetate. The mixture was shaken with 250 rpm for 30 min. 
Phase separation was facilitated by centrifugation at 16,000 x g for 1 min at RT. The 
extracted products were applied to 3H scintillation counting. 
4.13.2 Tri-peptide formation  
In order to quantify non-radioactive Pro-tRNAPro, initiation complexes (0.15 µM) primed 
with fMPF mRNA in the presence of 2 µM [14C]Phe-TC, 1 µM EF-G and 3 µM EF-P were 
titrated with increasing concentrations of Pro-tRNAPro. The reaction was allowed to 
proceed at 37°C for 1 min and quenched with KOH (0.5 mM). The peptidyl-tRNA was 
hydrolyzed by incubation at 37°C for 30 min. Prior to applying the samples to an HPLC 
system, the reaction mix was centrifuged at 16,000 rcf for 15 min at 4°C. The supernatant 
was diluted with HPLC buffer A (Table 10) to a final volume of 200 µl and applied via a 
HPLC unit 2695 (Waters) to a Chromolith® Performance RP-8e reversed phase column. 
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The eluate was fractionated in 0.5 ml fractions, applied to double scintillation counting 
and the yield plotted. The incorporation of cold Pro is required to form the tri-peptide 
product. Hence, the 14C counts reflect the proline concentration. 
4.13.3 Penta-peptide formation 
In vitro translation was performed by mixing initiation complex (0.2 µM) primed with an 
mRNA coding for fMPPPF, Pro- and Phe-TC (2 µM each), EF-G (1 µM) and EF-P (varying 
concentrations) in HiFi buffer at 37°C. The reaction was allowed to proceed for 20 s and 
subsequently quenched with KOH (0.5 M). The product was hydrolyzed for 30 min at 37°C 
and neutralized with glacial acetic acid. The reaction mix was centrifuged at 16,000 rcf for 
15 min at 4°C. The product was separated from the substrates by reversed-phase HPLC 
using a Chromolith® Performance RP 8e reversed phase column. The eluate was 
fractionated in 0.5 ml fractions and applied to double scintillation counting. 
To monitor the formation of fMPPG from fMPP post-translocation complexes, 
fMPP complexes (0.1 µM), saturating concentrations of Gly-TC (10 µM) and 
sub-saturation concentrations of EF-P were rapidly mixed and incubated in HiFi for 37°C. 
The reaction mix was centrifuged at 16,000 rcf for 15 min at 4°C. The product was 
separated from the substrates by reversed-phase HPLC using a Chromolith® Performance 
RP 8e column. The eluate was fractionated in 0.5 ml fractions and applied to double 
scintillation counting. 
4.13.4 Peptidyl-tRNA drop off 
In order to study the peptidyl-tRNA drop off during translation, the amount of peptidyl-
tRNA bound to the ribosome was quantified. For this purpose, initiation complexes 
(0.3 µM) primed with an mRNA encoding fMPPG were incubated with Pro-TC (4 µM), 
Gly-TC (2 µM), EF-G (3 µM) in the presence or absence of either EF-P (3 µM) or EFP-like 
protein (3 µM) in HiFi at 37°C for 120 s. The reaction mix was applied on a 0.2 µm 
nitrocellulose filter (Sartorius), allowing free tRNAs to path through, while tRNAs bound to 
the ribosome were retained. In order to reduce unspecific binding of free tRNAs the filter 
were washed with 5 ml ice cold HiFi buffer. The retained tRNAs were quantified by 
scintillation counting. 
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4.13.5 Pulse-chase experiment 
In order to gain mechanistic insights into how EF-P facilitates peptide bond formation a 
pulse-chase experiment was performed. The amplitude of the reaction reflects the 
commitment of EF-P to perform catalysis over dissociation and will give insights whether 
binding leads immediately to catalysis or requires multiple rounds of binding. 
Post-translocation complexes (fMPP) primed with mRNA encoding fMPPG were used and 
the incorporation of glycine was monitored. The experiments were performed in a 
quench-flow apparatus using HiFi buffer at 37°C. The pulse-chase was performed by 
rapidly mixing of post-translocation complexes (0.4 µM) and EF-P (2 µM) with 
Gly-TC (6.6 µM) and EF-P (K34A) (20 µM). To establish the potential amplitude of the 
pulse chase experiment the reaction was monitored in the absence of unreactive EF-P 
variants (maximum amplitude) and with unreactive EF-P in the start mix 
(minimum amplitude). The chase was measured in the presence of both the reactive and 
unreactive EF-P in the start mix. The maximum amplitude was determined by rapidly 
mixing of post-translocation complexes (0.4 µM) and EF-P (K34A) (10 µM) with 
Gly-TC (6.6 µM) and EF-P K34A (10 µM). The minimum amplitude was determined by 
rapidly mixing of post-translocation complexes (0.4 µM) and EF-P (1 µM) with 
Gly-TC (6.6 µM) and EF-P (1 µM). The chase was carried out by rapidly mixing of post-
translocation complexes (0.4 µM), EF-P (2 µM) and EF-P K34A (20 µM) with 
Gly-TC (6.6 µM). The reactions were quenched after 0.02, 2 and 20 s with KOH (0.5 M). 
The products were hydrolyzed for 30 min at 37°C and neutralized with glacial acetic acid. 
The reaction mix was centrifuged at 16,000 rcf for 15 min at 4°C. The product was 
separated from the substrates by reversed-phase HPLC using a Chromolith® Performance 
RP 8e column. The eluate was fractionated in 0.5 ml fractions and applied to double 
scintillation counting. 
 Mass-spectrometry 4.14
4.14.1 Sample preparation for mass spectrometry 
In order to quantify the cellular concentration of EF-P in E. coli cell samples were 
prepared. The cells were cultured in either LB broth at 37°C shaking with 200 rpm, in a 2 l 
glass flask containing 500 ml medium. One OD600 of cells was harvested during their 
exponential growth phase at an OD600 of 0.5 by centrifugation with 16,000 x g for 5 min. 
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The cell pellets were dissolved in SDS sample buffer and denatured at 95°C for 5 min. The 
samples corresponding to a 0.1 OD600 of cells were applied to an SDS PAGE and allowed to 
enter the separation gel for 1 cm. In order to establish correct factors that account for 
differences in peptide ionizability, EF-P fusion proteins were created. The proteins were 
digested in gel as described in the following section (4.14.2). 
4.14.2 In-gel digest and peptide extraction 
Prior to the in-gel digestion, the gel strips containing the protein of interest were cut out 
of the gel, crushed, and washed with water for 5 min at RT. After removal of the liquids, 
the gel pieces were shrunk by applying 150 µl acetonitrile and incubation for 15 min 
shaking with 150 rpm at RT. The supernatant was removed, and the gel pieces dried in a 
speed-vac. The proteins inside the gel pieces were reduced with 10 mM DTT (in 50 mM 
ammonium hydrogen carbonate) at 56°C shaking with 150 rpm for 60 min. The gel pieces 
were again shrunken using acetonitrile. The reduced cysteine moieties were conjugated 
to iodoacetamide by using 55 mM iodoacetamide in 50 mM ammonium hydrogen 
carbonate. The gel pieces were washed with 50 mM ammonium hydrogen carbonate and 
twice dehydrated with acetonitrile prior to in-gel digestion. 
The gel pieces were rehydrated with digestion buffer on ice for 45 min. The digestion 
buffer contained trpysin (12.5 ng/µl) solved in 50 mM ammonium hydrogen carbonate 
and 0.5 mM calcium chloride solution. The digestion was performed overnight at 37°C. To 
avoid dehydration the gel pieces covered with digestion buffer lacking the corresponding 
protease. 
The peptides were extracted by adding 5% formic acid and acetonitrile. The samples were 
dried in a speed-vac and the peptides were dissolved in 10% acetonitrile and 0.1% formic 
acid solution. 
4.14.3 Quantification of intracellular EF-P by mass spectrometry 
The proteolyzed peptides were analyzed by a UPLC-ESI-MS/MS system (Dionex Ultimate 
3000 UPLC connected to a QExcative Plus mass spectrometer) and an untargeted 
data-dependent (DDA) acquisition was performed. RAW files were analyzed using the 
MaxQuant software (version1.5.2.8) and searched against the UniProt E. coli (K12) 
proteome as reference. Results were analyzed in the Skyline software. The highest 
populated charge states of most intense peptides with suitable elution profiles were 
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selected for targeted acquisition. Those peptides were quantified in the proteolyzed 
fusionproteins and the E.coli lysate. Precusors were isolated in a 1 m/z isolation window,  
in a maximum fill time of 100ms and an automatic gain of 5x105. Precusor peptides were 
fragmented by HCD at a collsion energy of 30 eV and detected at set resolution of 60000 
in the orbitrap. Fragment elution profiles of the individual peptides were extracted and 
integrated inSkyline software 3.5. The integrated area of each fusion-protein derived EF-P 
or L4/L17 peptide was used to form their ratio which was corrected by the established 
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Table 16: Primers used in this study 
Name Sequence Function 
OF3 ggcggtGGTGGCAAACCGGCTACC Truncation 
OF4 TTTGCCACCaccgccGCCCGGATCGGTATCAACG  
OF5 GTTGAACTGGAAATCGTTGATgcgGATCCGGGCCTGAAAGGTG EF-P T146A 
OF6 CACCTTTCAGGCCCGGATCcgcATCAACGATTTCCAGTTCAAC  
OF7 GAACTGGAAATCGTTGATgtgGATCCGGGCCTGAAAGG EF-P T146V 
OF8 CCTTTCAGGCCCGGATCcacATCAACGATTTCCAGTTC  
OF33 Tagcaaggagatatacatctgcagccactgagatcc EF-P YjeA YjeK  
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OF34.1 atgtatatctccttgctagcgTTAC  
OF35 taagaaggagatatacatAcgctagcaaggagatatacatc EF-P YjeA 
OF36 atatctccttgctagcgTatgtatatctccttcttaaagttaaaca  
OF37 taagaaggagatatacatggatcccctctagaaataatt EF-P 
OF38.1 ATGTATATCTCCTTCTTAAAGTTAAAC  
OF39* Ctgcagccactgagatcc EF-P YjeA YjeK 
OF40 ggatctcagtggctgcagTTACTGCTGGCGTAGCTG  
OF41 ggatctcagtggctgcagTTATGCCCGGTCAACG EF-P YjeA * 
OF42 ggatctcagtggctgcagTTACTTCACGCGAGAGACG EF-P * 
OF49 AAGGTatTACCGCAGGTACTGG EF-P D145L 
OF50 TGCGGTAatACCTTTCAGGC  
OF51 AAGGTGtgACCGCAGGTACTG EF-P D145V 
OF52 TGCGGTcaCACCTTTCAGG  
OF53 AAGGTGATgCgGCAGGTACTGG EF-P T146A 
OF54 TACCTGCcGcATCACCTTTCAG  
OF55 AAGGTGATgtgGCAGGTACTGGTG EF-P T146V 
OF56 TACCTGCcacATCACCTTTCAGG  
OF71 TACGTCTCTCGCGTGAAGTAAATGGAATTAGTATTGAAAGACGC EF-P-L4*,#,+ 
OF82 ccggatctcagtggctgcagTCATGCCAGCATCTCCTC  
OF83 TACGTCTCTCGCGTGAAGTAAATGCGCCATCGTAAGAGTG EF-P-L16*,#,+ 
OF74 ccggatctcagtggctgcagTTACTCTGCAGCAGCTTCTGC  
OF75 TTACTTCACGCGAGAGACGTATTC  
OF76 Atggctgccgcgc  
OF77 tggtgccgcgcggcagccatATGTCTGACGAAGAACATACCTTTG eIF5A 
OF78 TTAATCGGTTCTAGCAGCTTCC  
OF79 AAGCTGCTAGAACCGATTAAATGTCCCGTCCACAAGTTACTG eIF5A-L4 
OF84 ccggatctcagtggctgcagTTAATCGTGTTTCAAAGTTTCGG  




Figure 29: HPLC gradient profile of solvent B used for peptide seperation. 
Apply gradient of solvent B over time during a HPLC run on a reverse-phase chromatography 
column to separate poly-proline containing peptides from substrates and intermediates. Using 
a Chromolith® Performance RP8e 100-4.6 mm column, solvent A 0% acetonitrile and solvent B 




Figure 30: Thermostability of EF-P tested by ProteoPlex. 
A) Comparison of the ProteoPlex analysis of EF-P (wt), EF-P (D66C) and EF-P (K34A). With 
increasing temperature the protein becomes unfolded, resulting in the exposure of 
hydrophobic side chains to the solvent. The fluorescent signal arises due to interactions of 
hydrophobic side chains and the dye in solution. For EF-P (wt) and the established labeling 
variant EF-P (D66C) the same thermostability was found, where as EF-P (K34A) appears to have 
a reduced thermostability. Showing the same unfolding behavior Showing the same unfolding 
behavior.  
B) Thermostability of EF-P (wt). 
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using CPMG-RD-NMR 
  
2008 – 2011 Bachelor in Biology (B.Sc.) at the Leibniz University of Hannover 
 Thesis: “Analysis of the heterologous expression of the 
Ansamitocin-amidsynthase (Asm9) from Actinosynnema 
pretiosum and large scale mutabiosynthesis of N-desmethyl-
ansamitocin.” at the Institute of Organic Chemistry 
 
2005 – 2008 Wilhelm-Busch-Gymnasium in Stadthagen, Abitur  
 
International experiences 
2012 – 2013 Research stay at the University of Cambridge, Department of 
Biochemistry, Cambridge, UK 
 Heterologous production of the natural product nigericin 
 
Leadership and social activities 
2014 – 2017 Student representative of the “Göttingen graduate school of 
Neurosciences, Biophysics, and Molecular Biosciences” (GGNB) 
 Negotiate and represent the students interest in front of the 
Curriculum vitae 
129 
GGNB board, the president of the University and during the 




2015 – 2016 PhD student representative of the “Georg-August University 
School of Science” (GAUSS) 
 Representation of the students interests at the GAUSS board 




2014 Max Planck Doctoral stipend 
  
2014 Cambridge European Scholarships 
  




 Participant at the 12th Intercultural communication workshop:  
“Working across borders, communicating across cultures“ by Petersen & Petersen 
 Seminar on “Medical chemistry“ by Abbott Laboratories 
 Course on “Viral transfection systems” including S2 work at German Primate Center 
 Seminar on “Project management for young scientists“ by Golin Managment 
 Course on “Drug Discovery and Project Management in the Pharmaceutical 
Industry” by Dr. Willmar Schwabe Arzneimittel GmbH & Co. KGa 
  Certificate on Good Manufacturing Practice by Sartorius, Juno Therapeutics and 
other companies 
 
Personal interests  























For what is a man, what has he got 
If not himself, then he has naught 
To say the things he truly feels 
And not the words of one who kneels 
The record shows I took the blows 
And did it my way 
Yes, it was my way 
 
Frank Sinatra, 
I did it my way
 
 
 
  
 
 
 
